| ENSG00000152931.7 |
Cytarabine |
Bladder urothelial carcinoma |
0.026226955 |
Resistant |
| ENSG00000183674.7 |
Cytarabine |
Bladder urothelial carcinoma |
0.043053789 |
Resistant |
| ENSG00000203280.3 |
Cytarabine |
Bladder urothelial carcinoma |
0.035341098 |
Resistant |
| ENSG00000224292.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.040029744 |
Resistant |
| ENSG00000225138.3 |
Cytarabine |
Bladder urothelial carcinoma |
0.034818586 |
Resistant |
| ENSG00000227200.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.040176905 |
Resistant |
| ENSG00000231367.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.037613413 |
Resistant |
| ENSG00000237870.2 |
Cytarabine |
Bladder urothelial carcinoma |
0.01550661 |
Resistant |
| ENSG00000240006.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.036971837 |
Resistant |
| ENSG00000253284.2 |
Cytarabine |
Bladder urothelial carcinoma |
0.020566969 |
Resistant |
| ENSG00000258378.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.007791278 |
Resistant |
| ENSG00000259182.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.014486605 |
Resistant |
| ENSG00000259727.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.032971463 |
Resistant |
| ENSG00000260805.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.001027332 |
Resistant |
| ENSG00000261124.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.041411062 |
Resistant |
| ENSG00000264673.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.041382432 |
Resistant |
| ENSG00000267454.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.004618191 |
Resistant |
| ENSG00000271359.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.048742791 |
Resistant |
| ENSG00000179219.5 |
Cytarabine |
Breast invasive carcinoma |
0.033975209 |
Resistant |
| ENSG00000179406.6 |
Cytarabine |
Breast invasive carcinoma |
0.028516499 |
Resistant |
| ENSG00000181097.5 |
Cytarabine |
Breast invasive carcinoma |
0.004819745 |
Resistant |
| ENSG00000182109.3 |
Cytarabine |
Breast invasive carcinoma |
0.037277188 |
Resistant |
| ENSG00000185203.7 |
Cytarabine |
Breast invasive carcinoma |
0.02574437 |
Resistant |
| ENSG00000188206.5 |
Cytarabine |
Breast invasive carcinoma |
0.018235613 |
Resistant |
| ENSG00000189419.5 |
Cytarabine |
Breast invasive carcinoma |
0.01137746 |
Resistant |
| ENSG00000203288.3 |
Cytarabine |
Breast invasive carcinoma |
0.015770866 |
Resistant |
| ENSG00000203496.4 |
Cytarabine |
Breast invasive carcinoma |
0.010902648 |
Resistant |
| ENSG00000203499.6 |
Cytarabine |
Breast invasive carcinoma |
0.036644122 |
Resistant |
| ENSG00000203585.3 |
Cytarabine |
Breast invasive carcinoma |
0.048659374 |
Resistant |
| ENSG00000203601.3 |
Cytarabine |
Breast invasive carcinoma |
0.040977214 |
Resistant |
| ENSG00000204832.5 |
Cytarabine |
Breast invasive carcinoma |
0.039876532 |
Resistant |
| ENSG00000205037.2 |
Cytarabine |
Breast invasive carcinoma |
0.026972154 |
Resistant |
| ENSG00000215023.2 |
Cytarabine |
Breast invasive carcinoma |
0.03575701 |
Resistant |
| ENSG00000223473.1 |
Cytarabine |
Breast invasive carcinoma |
0.030175047 |
Resistant |
| ENSG00000223635.1 |
Cytarabine |
Breast invasive carcinoma |
0.029608765 |
Resistant |
| ENSG00000224660.1 |
Cytarabine |
Breast invasive carcinoma |
0.00837551 |
Resistant |
| ENSG00000224794.1 |
Cytarabine |
Breast invasive carcinoma |
0.015992282 |
Resistant |
| ENSG00000224884.1 |
Cytarabine |
Breast invasive carcinoma |
0.024734498 |
Resistant |
| ENSG00000224888.3 |
Cytarabine |
Breast invasive carcinoma |
0.037569178 |
Resistant |
| ENSG00000225180.2 |
Cytarabine |
Breast invasive carcinoma |
0.015053325 |
Resistant |
| ENSG00000225234.1 |
Cytarabine |
Breast invasive carcinoma |
0.044395661 |
Resistant |
| ENSG00000225265.1 |
Cytarabine |
Breast invasive carcinoma |
0.023048521 |
Resistant |
| ENSG00000225506.2 |
Cytarabine |
Breast invasive carcinoma |
0.01271753 |
Resistant |
| ENSG00000225555.1 |
Cytarabine |
Breast invasive carcinoma |
0.008513786 |
Resistant |
| ENSG00000226101.1 |
Cytarabine |
Breast invasive carcinoma |
0.033856975 |
Resistant |
| ENSG00000226310.1 |
Cytarabine |
Breast invasive carcinoma |
0.028732433 |
Resistant |
| ENSG00000226581.1 |
Cytarabine |
Breast invasive carcinoma |
0.041495373 |
Resistant |
| ENSG00000226686.3 |
Cytarabine |
Breast invasive carcinoma |
0.017643404 |
Resistant |
| ENSG00000226754.1 |
Cytarabine |
Breast invasive carcinoma |
0.042015184 |
Resistant |
| ENSG00000226853.2 |
Cytarabine |
Breast invasive carcinoma |
0.047266547 |
Resistant |
| ENSG00000226891.2 |
Cytarabine |
Breast invasive carcinoma |
0.037637152 |
Resistant |
| ENSG00000226957.1 |
Cytarabine |
Breast invasive carcinoma |
0.023271027 |
Resistant |
| ENSG00000227116.1 |
Cytarabine |
Breast invasive carcinoma |
0.024898623 |
Resistant |
| ENSG00000227527.2 |
Cytarabine |
Breast invasive carcinoma |
0.049146002 |
Resistant |
| ENSG00000227603.1 |
Cytarabine |
Breast invasive carcinoma |
0.041614964 |
Resistant |
| ENSG00000227630.2 |
Cytarabine |
Breast invasive carcinoma |
0.042537361 |
Resistant |
| ENSG00000228386.2 |
Cytarabine |
Breast invasive carcinoma |
0.045948552 |
Resistant |
| ENSG00000228634.1 |
Cytarabine |
Breast invasive carcinoma |
0.000308344 |
Resistant |
| ENSG00000228701.1 |
Cytarabine |
Breast invasive carcinoma |
0.034361759 |
Resistant |
| ENSG00000228775.3 |
Cytarabine |
Breast invasive carcinoma |
0.006288177 |
Resistant |
| ENSG00000228801.5 |
Cytarabine |
Breast invasive carcinoma |
0.017372904 |
Resistant |
| ENSG00000228917.1 |
Cytarabine |
Breast invasive carcinoma |
0.047392834 |
Resistant |
| ENSG00000228972.1 |
Cytarabine |
Breast invasive carcinoma |
0.021305381 |
Resistant |
| ENSG00000228973.1 |
Cytarabine |
Breast invasive carcinoma |
0.040255157 |
Resistant |
| ENSG00000229137.2 |
Cytarabine |
Breast invasive carcinoma |
0.043586571 |
Resistant |
| ENSG00000229536.1 |
Cytarabine |
Breast invasive carcinoma |
0.043257274 |
Resistant |
| ENSG00000229848.1 |
Cytarabine |
Breast invasive carcinoma |
0.031527786 |
Resistant |
| ENSG00000230054.1 |
Cytarabine |
Breast invasive carcinoma |
0.0334642 |
Resistant |
| ENSG00000230487.3 |
Cytarabine |
Breast invasive carcinoma |
0.010686091 |
Resistant |
| ENSG00000230513.1 |
Cytarabine |
Breast invasive carcinoma |
0.007702597 |
Resistant |
| ENSG00000230606.6 |
Cytarabine |
Breast invasive carcinoma |
0.017336871 |
Resistant |
| ENSG00000230736.2 |
Cytarabine |
Breast invasive carcinoma |
0.008456549 |
Resistant |
| ENSG00000230825.1 |
Cytarabine |
Breast invasive carcinoma |
0.041255027 |
Resistant |
| ENSG00000230939.1 |
Cytarabine |
Breast invasive carcinoma |
0.011844671 |
Resistant |
| ENSG00000231249.1 |
Cytarabine |
Breast invasive carcinoma |
0.031624471 |
Resistant |
| ENSG00000231439.3 |
Cytarabine |
Breast invasive carcinoma |
0.013536445 |
Resistant |
| ENSG00000231711.2 |
Cytarabine |
Breast invasive carcinoma |
0.016188739 |
Resistant |
| ENSG00000231856.1 |
Cytarabine |
Breast invasive carcinoma |
0.012771701 |
Resistant |
| ENSG00000232124.1 |
Cytarabine |
Breast invasive carcinoma |
0.042008806 |
Resistant |
| ENSG00000232347.1 |
Cytarabine |
Breast invasive carcinoma |
0.005470485 |
Resistant |
| ENSG00000232536.1 |
Cytarabine |
Breast invasive carcinoma |
0.042242473 |
Resistant |
| ENSG00000232600.2 |
Cytarabine |
Breast invasive carcinoma |
0.016310144 |
Resistant |
| ENSG00000232710.1 |
Cytarabine |
Breast invasive carcinoma |
0.036084974 |
Resistant |
| ENSG00000233008.1 |
Cytarabine |
Breast invasive carcinoma |
0.021251402 |
Resistant |
| ENSG00000234617.1 |
Cytarabine |
Breast invasive carcinoma |
0.036804009 |
Resistant |
| ENSG00000234789.1 |
Cytarabine |
Breast invasive carcinoma |
0.038737107 |
Resistant |
| ENSG00000234869.1 |
Cytarabine |
Breast invasive carcinoma |
0.003365662 |
Resistant |
| ENSG00000234899.5 |
Cytarabine |
Breast invasive carcinoma |
0.037353334 |
Resistant |
| ENSG00000235092.1 |
Cytarabine |
Breast invasive carcinoma |
0.02038196 |
Resistant |
| ENSG00000235159.1 |
Cytarabine |
Breast invasive carcinoma |
0.01586149 |
Resistant |
| ENSG00000235437.3 |
Cytarabine |
Breast invasive carcinoma |
0.025707852 |
Resistant |
| ENSG00000236199.1 |
Cytarabine |
Breast invasive carcinoma |
0.004405643 |
Resistant |
| ENSG00000236514.1 |
Cytarabine |
Breast invasive carcinoma |
0.004377787 |
Resistant |
| ENSG00000236617.2 |
Cytarabine |
Breast invasive carcinoma |
0.013721438 |
Resistant |
| ENSG00000236682.1 |
Cytarabine |
Breast invasive carcinoma |
0.015206729 |
Resistant |
| ENSG00000237015.1 |
Cytarabine |
Breast invasive carcinoma |
0.033240054 |
Resistant |
| ENSG00000237037.5 |
Cytarabine |
Breast invasive carcinoma |
0.016023674 |
Resistant |
| ENSG00000237461.1 |
Cytarabine |
Breast invasive carcinoma |
0.049470949 |
Resistant |
| ENSG00000237520.1 |
Cytarabine |
Breast invasive carcinoma |
0.012710082 |
Resistant |
| ENSG00000237588.2 |
Cytarabine |
Breast invasive carcinoma |
0.023844536 |
Resistant |
| ENSG00000237689.1 |
Cytarabine |
Breast invasive carcinoma |
0.03044851 |
Resistant |
| ENSG00000237756.1 |
Cytarabine |
Breast invasive carcinoma |
0.018907703 |
Resistant |
| ENSG00000237772.1 |
Cytarabine |
Breast invasive carcinoma |
0.025359246 |
Resistant |
| ENSG00000238005.2 |
Cytarabine |
Breast invasive carcinoma |
0.00596338 |
Resistant |
| ENSG00000239002.2 |
Cytarabine |
Breast invasive carcinoma |
0.009150092 |
Resistant |
| ENSG00000239480.1 |
Cytarabine |
Breast invasive carcinoma |
0.039415075 |
Resistant |
| ENSG00000239664.2 |
Cytarabine |
Breast invasive carcinoma |
0.042216179 |
Resistant |
| ENSG00000239911.1 |
Cytarabine |
Breast invasive carcinoma |
0.031786482 |
Resistant |
| ENSG00000240405.1 |
Cytarabine |
Breast invasive carcinoma |
0.040080462 |
Resistant |
| ENSG00000240541.2 |
Cytarabine |
Breast invasive carcinoma |
0.007991662 |
Resistant |
| ENSG00000240859.1 |
Cytarabine |
Breast invasive carcinoma |
0.044561851 |
Resistant |
| ENSG00000241481.2 |
Cytarabine |
Breast invasive carcinoma |
0.021662051 |
Resistant |
| ENSG00000241954.1 |
Cytarabine |
Breast invasive carcinoma |
0.017230426 |
Resistant |
| ENSG00000243008.2 |
Cytarabine |
Breast invasive carcinoma |
0.048583396 |
Resistant |
| ENSG00000243885.1 |
Cytarabine |
Breast invasive carcinoma |
0.021559537 |
Resistant |
| ENSG00000246465.1 |
Cytarabine |
Breast invasive carcinoma |
0.043239008 |
Resistant |
| ENSG00000246526.2 |
Cytarabine |
Breast invasive carcinoma |
0.033326682 |
Resistant |
| ENSG00000247317.3 |
Cytarabine |
Breast invasive carcinoma |
0.006492817 |
Resistant |
| ENSG00000247853.2 |
Cytarabine |
Breast invasive carcinoma |
0.001885079 |
Resistant |
| ENSG00000249602.1 |
Cytarabine |
Breast invasive carcinoma |
0.009047588 |
Resistant |
| ENSG00000249859.3 |
Cytarabine |
Breast invasive carcinoma |
0.046812902 |
Resistant |
| ENSG00000251151.2 |
Cytarabine |
Breast invasive carcinoma |
0.044312521 |
Resistant |
| ENSG00000251562.3 |
Cytarabine |
Breast invasive carcinoma |
0.025496989 |
Resistant |
| ENSG00000253433.1 |
Cytarabine |
Breast invasive carcinoma |
0.043998248 |
Resistant |
| ENSG00000253741.1 |
Cytarabine |
Breast invasive carcinoma |
0.031471382 |
Resistant |
| ENSG00000254153.1 |
Cytarabine |
Breast invasive carcinoma |
0.046836726 |
Resistant |
| ENSG00000254231.1 |
Cytarabine |
Breast invasive carcinoma |
0.006851133 |
Resistant |
| ENSG00000254263.1 |
Cytarabine |
Breast invasive carcinoma |
0.028819373 |
Resistant |
| ENSG00000254632.1 |
Cytarabine |
Breast invasive carcinoma |
0.032829766 |
Resistant |
| ENSG00000254812.1 |
Cytarabine |
Breast invasive carcinoma |
0.013425671 |
Resistant |
| ENSG00000255164.1 |
Cytarabine |
Breast invasive carcinoma |
0.007367659 |
Resistant |
| ENSG00000255966.1 |
Cytarabine |
Breast invasive carcinoma |
0.019953979 |
Resistant |
| ENSG00000256381.1 |
Cytarabine |
Breast invasive carcinoma |
0.02867529 |
Resistant |
| ENSG00000256564.1 |
Cytarabine |
Breast invasive carcinoma |
0.02531107 |
Resistant |
| ENSG00000257830.1 |
Cytarabine |
Breast invasive carcinoma |
0.022095974 |
Resistant |
| ENSG00000257999.1 |
Cytarabine |
Breast invasive carcinoma |
0.022345278 |
Resistant |
| ENSG00000258172.1 |
Cytarabine |
Breast invasive carcinoma |
0.046418556 |
Resistant |
| ENSG00000258457.1 |
Cytarabine |
Breast invasive carcinoma |
0.043257099 |
Resistant |
| ENSG00000258593.2 |
Cytarabine |
Breast invasive carcinoma |
0.023088584 |
Resistant |
| ENSG00000258851.1 |
Cytarabine |
Breast invasive carcinoma |
0.01437152 |
Resistant |
| ENSG00000258940.2 |
Cytarabine |
Breast invasive carcinoma |
0.009089702 |
Resistant |
| ENSG00000258999.1 |
Cytarabine |
Breast invasive carcinoma |
0.025094521 |
Resistant |
| ENSG00000259038.1 |
Cytarabine |
Breast invasive carcinoma |
0.002857248 |
Resistant |
| ENSG00000259163.1 |
Cytarabine |
Breast invasive carcinoma |
0.044448249 |
Resistant |
| ENSG00000259319.1 |
Cytarabine |
Breast invasive carcinoma |
0.033282251 |
Resistant |
| ENSG00000259362.2 |
Cytarabine |
Breast invasive carcinoma |
0.023641873 |
Resistant |
| ENSG00000259438.1 |
Cytarabine |
Breast invasive carcinoma |
0.013898305 |
Resistant |
| ENSG00000259654.1 |
Cytarabine |
Breast invasive carcinoma |
0.008898888 |
Resistant |
| ENSG00000259673.1 |
Cytarabine |
Breast invasive carcinoma |
0.019029289 |
Resistant |
| ENSG00000259727.1 |
Cytarabine |
Breast invasive carcinoma |
0.034679978 |
Resistant |
| ENSG00000259762.1 |
Cytarabine |
Breast invasive carcinoma |
0.007112015 |
Resistant |
| ENSG00000259783.1 |
Cytarabine |
Breast invasive carcinoma |
0.005701349 |
Resistant |
| ENSG00000259820.1 |
Cytarabine |
Breast invasive carcinoma |
0.029497348 |
Resistant |
| ENSG00000259867.1 |
Cytarabine |
Breast invasive carcinoma |
0.018086043 |
Resistant |
| ENSG00000259891.1 |
Cytarabine |
Breast invasive carcinoma |
0.012864141 |
Resistant |
| ENSG00000259894.1 |
Cytarabine |
Breast invasive carcinoma |
0.035625 |
Resistant |
| ENSG00000260081.1 |
Cytarabine |
Breast invasive carcinoma |
0.039100975 |
Resistant |
| ENSG00000260156.1 |
Cytarabine |
Breast invasive carcinoma |
0.007307608 |
Resistant |
| ENSG00000260368.1 |
Cytarabine |
Breast invasive carcinoma |
0.029620964 |
Resistant |
| ENSG00000260470.1 |
Cytarabine |
Breast invasive carcinoma |
0.024836532 |
Resistant |
| ENSG00000260613.1 |
Cytarabine |
Breast invasive carcinoma |
0.018831884 |
Resistant |
| ENSG00000260619.1 |
Cytarabine |
Breast invasive carcinoma |
0.023077152 |
Resistant |
| ENSG00000260672.1 |
Cytarabine |
Breast invasive carcinoma |
0.024394053 |
Resistant |
| ENSG00000260698.1 |
Cytarabine |
Breast invasive carcinoma |
0.006265456 |
Resistant |
| ENSG00000260750.1 |
Cytarabine |
Breast invasive carcinoma |
0.034953474 |
Resistant |
| ENSG00000260805.1 |
Cytarabine |
Breast invasive carcinoma |
0.019061233 |
Resistant |
| ENSG00000261003.1 |
Cytarabine |
Breast invasive carcinoma |
0.047762942 |
Resistant |
| ENSG00000261220.2 |
Cytarabine |
Breast invasive carcinoma |
0.020519158 |
Resistant |
| ENSG00000261324.2 |
Cytarabine |
Breast invasive carcinoma |
0.017556518 |
Resistant |
| ENSG00000261390.1 |
Cytarabine |
Breast invasive carcinoma |
0.03128989 |
Resistant |
| ENSG00000261431.1 |
Cytarabine |
Breast invasive carcinoma |
0.042035413 |
Resistant |
| ENSG00000261437.1 |
Cytarabine |
Breast invasive carcinoma |
0.023669396 |
Resistant |
| ENSG00000261442.1 |
Cytarabine |
Breast invasive carcinoma |
0.015615696 |
Resistant |
| ENSG00000261474.1 |
Cytarabine |
Breast invasive carcinoma |
0.007029338 |
Resistant |
| ENSG00000261693.1 |
Cytarabine |
Breast invasive carcinoma |
0.030916007 |
Resistant |
| ENSG00000261744.1 |
Cytarabine |
Breast invasive carcinoma |
0.001504925 |
Resistant |
| ENSG00000262693.1 |
Cytarabine |
Breast invasive carcinoma |
0.040121173 |
Resistant |
| ENSG00000263098.1 |
Cytarabine |
Breast invasive carcinoma |
0.029825494 |
Resistant |
| ENSG00000263120.1 |
Cytarabine |
Breast invasive carcinoma |
0.040684265 |
Resistant |
| ENSG00000263214.1 |
Cytarabine |
Breast invasive carcinoma |
0.047717416 |
Resistant |
| ENSG00000264207.1 |
Cytarabine |
Breast invasive carcinoma |
0.035956472 |
Resistant |
| ENSG00000264672.1 |
Cytarabine |
Breast invasive carcinoma |
0.03365496 |
Resistant |
| ENSG00000266947.1 |
Cytarabine |
Breast invasive carcinoma |
0.028096912 |
Resistant |
| ENSG00000266999.1 |
Cytarabine |
Breast invasive carcinoma |
0.04618698 |
Resistant |
| ENSG00000267130.1 |
Cytarabine |
Breast invasive carcinoma |
0.023654628 |
Resistant |
| ENSG00000267131.1 |
Cytarabine |
Breast invasive carcinoma |
0.031757532 |
Resistant |
| ENSG00000267296.2 |
Cytarabine |
Breast invasive carcinoma |
0.019925438 |
Resistant |
| ENSG00000267481.1 |
Cytarabine |
Breast invasive carcinoma |
0.023930499 |
Resistant |
| ENSG00000267672.1 |
Cytarabine |
Breast invasive carcinoma |
0.01791284 |
Resistant |
| ENSG00000268095.1 |
Cytarabine |
Breast invasive carcinoma |
0.026667439 |
Resistant |
| ENSG00000268683.1 |
Cytarabine |
Breast invasive carcinoma |
0.020421948 |
Resistant |
| ENSG00000269887.1 |
Cytarabine |
Breast invasive carcinoma |
0.018789422 |
Resistant |
| ENSG00000270022.2 |
Cytarabine |
Breast invasive carcinoma |
0.049231697 |
Resistant |
| ENSG00000270028.1 |
Cytarabine |
Breast invasive carcinoma |
0.046760447 |
Resistant |
| ENSG00000270039.1 |
Cytarabine |
Breast invasive carcinoma |
0.004921557 |
Resistant |
| ENSG00000270115.1 |
Cytarabine |
Breast invasive carcinoma |
0.027641159 |
Resistant |
| ENSG00000270117.1 |
Cytarabine |
Breast invasive carcinoma |
0.003420499 |
Resistant |
| ENSG00000270120.1 |
Cytarabine |
Breast invasive carcinoma |
0.033708822 |
Resistant |
| ENSG00000270127.1 |
Cytarabine |
Breast invasive carcinoma |
0.031074574 |
Resistant |
| ENSG00000270742.1 |
Cytarabine |
Breast invasive carcinoma |
0.020797932 |
Resistant |
| ENSG00000270964.1 |
Cytarabine |
Breast invasive carcinoma |
0.018645906 |
Resistant |
| ENSG00000271324.1 |
Cytarabine |
Breast invasive carcinoma |
0.033206417 |
Resistant |
| ENSG00000271344.1 |
Cytarabine |
Breast invasive carcinoma |
0.048731937 |
Resistant |
| ENSG00000271367.1 |
Cytarabine |
Breast invasive carcinoma |
0.04280698 |
Resistant |
| ENSG00000271387.1 |
Cytarabine |
Breast invasive carcinoma |
0.0419373 |
Resistant |
| ENSG00000271430.1 |
Cytarabine |
Breast invasive carcinoma |
0.044418663 |
Resistant |
| ENSG00000271835.1 |
Cytarabine |
Breast invasive carcinoma |
0.005499663 |
Resistant |
| ENSG00000271983.1 |
Cytarabine |
Breast invasive carcinoma |
0.013054707 |
Resistant |
| ENSG00000272070.1 |
Cytarabine |
Breast invasive carcinoma |
0.044549929 |
Resistant |
| ENSG00000272071.1 |
Cytarabine |
Breast invasive carcinoma |
0.037553583 |
Resistant |
| ENSG00000272128.1 |
Cytarabine |
Breast invasive carcinoma |
0.012245512 |
Resistant |
| ENSG00000272161.1 |
Cytarabine |
Breast invasive carcinoma |
0.047226848 |
Resistant |
| ENSG00000272709.1 |
Cytarabine |
Breast invasive carcinoma |
0.041383303 |
Resistant |
| ENSG00000272791.1 |
Cytarabine |
Breast invasive carcinoma |
0.037107242 |
Resistant |
| ENSG00000272825.1 |
Cytarabine |
Breast invasive carcinoma |
0.049408354 |
Resistant |
| ENSG00000272940.1 |
Cytarabine |
Breast invasive carcinoma |
0.03810284 |
Resistant |
| ENSG00000273026.1 |
Cytarabine |
Breast invasive carcinoma |
0.004308142 |
Resistant |
| ENSG00000273058.1 |
Cytarabine |
Breast invasive carcinoma |
0.021210366 |
Resistant |
| ENSG00000273076.1 |
Cytarabine |
Breast invasive carcinoma |
0.029341141 |
Resistant |
| ENSG00000273145.1 |
Cytarabine |
Breast invasive carcinoma |
0.045266687 |
Resistant |
| ENSG00000273237.1 |
Cytarabine |
Breast invasive carcinoma |
0.049311798 |
Resistant |
| ENSG00000273265.1 |
Cytarabine |
Breast invasive carcinoma |
0.01119138 |
Resistant |
| ENSG00000273270.1 |
Cytarabine |
Breast invasive carcinoma |
0.036473353 |
Resistant |
| ENSG00000273406.1 |
Cytarabine |
Breast invasive carcinoma |
0.03320468 |
Resistant |
| ENSG00000273473.1 |
Cytarabine |
Breast invasive carcinoma |
0.036415418 |
Resistant |
| ENSG00000132832.5 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.029713487 |
Resistant |
| ENSG00000182586.3 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015561084 |
Resistant |
| ENSG00000196756.7 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028124621 |
Resistant |
| ENSG00000203288.3 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.011174124 |
Resistant |
| ENSG00000203497.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03542317 |
Resistant |
| ENSG00000223393.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030239768 |
Resistant |
| ENSG00000223935.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040450978 |
Resistant |
| ENSG00000224424.7 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.0379676 |
Resistant |
| ENSG00000224596.3 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032649189 |
Resistant |
| ENSG00000224699.4 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038711924 |
Resistant |
| ENSG00000225265.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043836262 |
Resistant |
| ENSG00000225335.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01469842 |
Resistant |
| ENSG00000227431.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037205485 |
Resistant |
| ENSG00000228775.3 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041367979 |
Resistant |
| ENSG00000230850.3 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.044446248 |
Resistant |
| ENSG00000231196.3 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001667355 |
Resistant |
| ENSG00000232874.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031242783 |
Resistant |
| ENSG00000232876.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04882558 |
Resistant |
| ENSG00000232907.3 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032676198 |
Resistant |
| ENSG00000234183.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.010805129 |
Resistant |
| ENSG00000235663.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014138874 |
Resistant |
| ENSG00000236859.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045762687 |
Resistant |
| ENSG00000239523.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014546761 |
Resistant |
| ENSG00000244198.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01385652 |
Resistant |
| ENSG00000246763.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.047202309 |
Resistant |
| ENSG00000246792.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04525645 |
Resistant |
| ENSG00000247796.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013204853 |
Resistant |
| ENSG00000249896.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000743704 |
Resistant |
| ENSG00000254468.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007938226 |
Resistant |
| ENSG00000254842.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.029900963 |
Resistant |
| ENSG00000256596.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041555888 |
Resistant |
| ENSG00000257337.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033991773 |
Resistant |
| ENSG00000259584.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042971338 |
Resistant |
| ENSG00000260118.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038308284 |
Resistant |
| ENSG00000260805.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001122677 |
Resistant |
| ENSG00000261770.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001370795 |
Resistant |
| ENSG00000267481.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024375244 |
Resistant |
| ENSG00000267606.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.021866791 |
Resistant |
| ENSG00000267776.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016119089 |
Resistant |
| ENSG00000270332.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009904006 |
Resistant |
| ENSG00000270761.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.004780166 |
Resistant |
| ENSG00000270828.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015625718 |
Resistant |
| ENSG00000271659.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048783377 |
Resistant |
| ENSG00000272426.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048208515 |
Resistant |
| ENSG00000272791.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030060697 |
Resistant |
| ENSG00000272892.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.0404798 |
Resistant |
| ENSG00000160336.10 |
Cytarabine |
Colon adenocarcinoma |
0.016975798 |
Resistant |
| ENSG00000174365.15 |
Cytarabine |
Colon adenocarcinoma |
0.006122153 |
Resistant |
| ENSG00000182376.2 |
Cytarabine |
Colon adenocarcinoma |
0.002277597 |
Resistant |
| ENSG00000196756.7 |
Cytarabine |
Colon adenocarcinoma |
0.030795646 |
Resistant |
| ENSG00000212694.4 |
Cytarabine |
Colon adenocarcinoma |
0.038002033 |
Resistant |
| ENSG00000222035.2 |
Cytarabine |
Colon adenocarcinoma |
0.017402144 |
Resistant |
| ENSG00000223855.1 |
Cytarabine |
Colon adenocarcinoma |
0.049072828 |
Resistant |
| ENSG00000224174.2 |
Cytarabine |
Colon adenocarcinoma |
0.04930977 |
Resistant |
| ENSG00000224799.1 |
Cytarabine |
Colon adenocarcinoma |
0.027112356 |
Resistant |
| ENSG00000225039.1 |
Cytarabine |
Colon adenocarcinoma |
0.045502073 |
Resistant |
| ENSG00000226310.1 |
Cytarabine |
Colon adenocarcinoma |
0.04751768 |
Resistant |
| ENSG00000227028.2 |
Cytarabine |
Colon adenocarcinoma |
0.002493526 |
Resistant |
| ENSG00000229065.1 |
Cytarabine |
Colon adenocarcinoma |
0.045149316 |
Resistant |
| ENSG00000229931.1 |
Cytarabine |
Colon adenocarcinoma |
0.030673386 |
Resistant |
| ENSG00000231083.1 |
Cytarabine |
Colon adenocarcinoma |
0.005859872 |
Resistant |
| ENSG00000231154.1 |
Cytarabine |
Colon adenocarcinoma |
0.009263445 |
Resistant |
| ENSG00000231217.1 |
Cytarabine |
Colon adenocarcinoma |
0.00642585 |
Resistant |
| ENSG00000231290.1 |
Cytarabine |
Colon adenocarcinoma |
0.043933437 |
Resistant |
| ENSG00000231536.1 |
Cytarabine |
Colon adenocarcinoma |
0.042164068 |
Resistant |
| ENSG00000231734.4 |
Cytarabine |
Colon adenocarcinoma |
0.023533333 |
Resistant |
| ENSG00000232455.2 |
Cytarabine |
Colon adenocarcinoma |
0.037128602 |
Resistant |
| ENSG00000234571.1 |
Cytarabine |
Colon adenocarcinoma |
0.039114989 |
Resistant |
| ENSG00000234698.1 |
Cytarabine |
Colon adenocarcinoma |
0.031575517 |
Resistant |
| ENSG00000234832.1 |
Cytarabine |
Colon adenocarcinoma |
0.01260802 |
Resistant |
| ENSG00000235123.1 |
Cytarabine |
Colon adenocarcinoma |
0.014774508 |
Resistant |
| ENSG00000235298.1 |
Cytarabine |
Colon adenocarcinoma |
0.022420133 |
Resistant |
| ENSG00000235313.1 |
Cytarabine |
Colon adenocarcinoma |
0.039005587 |
Resistant |
| ENSG00000236514.1 |
Cytarabine |
Colon adenocarcinoma |
0.033126975 |
Resistant |
| ENSG00000237595.2 |
Cytarabine |
Colon adenocarcinoma |
0.042463337 |
Resistant |
| ENSG00000237892.1 |
Cytarabine |
Colon adenocarcinoma |
0.037102824 |
Resistant |
| ENSG00000238142.1 |
Cytarabine |
Colon adenocarcinoma |
0.01577479 |
Resistant |
| ENSG00000239353.1 |
Cytarabine |
Colon adenocarcinoma |
0.018977288 |
Resistant |
| ENSG00000239462.1 |
Cytarabine |
Colon adenocarcinoma |
0.013223933 |
Resistant |
| ENSG00000240291.1 |
Cytarabine |
Colon adenocarcinoma |
0.045774114 |
Resistant |
| ENSG00000245648.1 |
Cytarabine |
Colon adenocarcinoma |
0.015075973 |
Resistant |
| ENSG00000253197.1 |
Cytarabine |
Colon adenocarcinoma |
0.002052436 |
Resistant |
| ENSG00000253395.1 |
Cytarabine |
Colon adenocarcinoma |
0.036277567 |
Resistant |
| ENSG00000253552.3 |
Cytarabine |
Colon adenocarcinoma |
0.040566373 |
Resistant |
| ENSG00000253641.1 |
Cytarabine |
Colon adenocarcinoma |
0.022452884 |
Resistant |
| ENSG00000254258.1 |
Cytarabine |
Colon adenocarcinoma |
0.016269081 |
Resistant |
| ENSG00000254397.1 |
Cytarabine |
Colon adenocarcinoma |
0.044944466 |
Resistant |
| ENSG00000255970.1 |
Cytarabine |
Colon adenocarcinoma |
0.034036883 |
Resistant |
| ENSG00000256588.1 |
Cytarabine |
Colon adenocarcinoma |
0.031147666 |
Resistant |
| ENSG00000258345.1 |
Cytarabine |
Colon adenocarcinoma |
0.003231644 |
Resistant |
| ENSG00000259172.1 |
Cytarabine |
Colon adenocarcinoma |
0.044844074 |
Resistant |
| ENSG00000259456.2 |
Cytarabine |
Colon adenocarcinoma |
0.002582346 |
Resistant |
| ENSG00000259488.1 |
Cytarabine |
Colon adenocarcinoma |
0.042199808 |
Resistant |
| ENSG00000259701.1 |
Cytarabine |
Colon adenocarcinoma |
0.043243056 |
Resistant |
| ENSG00000259723.1 |
Cytarabine |
Colon adenocarcinoma |
0.015669198 |
Resistant |
| ENSG00000260160.1 |
Cytarabine |
Colon adenocarcinoma |
0.022765458 |
Resistant |
| ENSG00000260213.1 |
Cytarabine |
Colon adenocarcinoma |
0.001111074 |
Resistant |
| ENSG00000260565.2 |
Cytarabine |
Colon adenocarcinoma |
0.044166292 |
Resistant |
| ENSG00000261758.1 |
Cytarabine |
Colon adenocarcinoma |
0.030843219 |
Resistant |
| ENSG00000261824.2 |
Cytarabine |
Colon adenocarcinoma |
0.04395336 |
Resistant |
| ENSG00000262136.1 |
Cytarabine |
Colon adenocarcinoma |
0.03946938 |
Resistant |
| ENSG00000263370.1 |
Cytarabine |
Colon adenocarcinoma |
0.034750046 |
Resistant |
| ENSG00000267152.1 |
Cytarabine |
Colon adenocarcinoma |
0.041759496 |
Resistant |
| ENSG00000267212.1 |
Cytarabine |
Colon adenocarcinoma |
0.048503709 |
Resistant |
| ENSG00000267298.1 |
Cytarabine |
Colon adenocarcinoma |
0.043231802 |
Resistant |
| ENSG00000268364.1 |
Cytarabine |
Colon adenocarcinoma |
0.044039904 |
Resistant |
| ENSG00000269614.1 |
Cytarabine |
Colon adenocarcinoma |
0.008100304 |
Resistant |
| ENSG00000270951.1 |
Cytarabine |
Colon adenocarcinoma |
0.002664651 |
Resistant |
| ENSG00000271009.2 |
Cytarabine |
Colon adenocarcinoma |
0.010266083 |
Resistant |
| ENSG00000271314.1 |
Cytarabine |
Colon adenocarcinoma |
0.028439978 |
Resistant |
| ENSG00000272029.1 |
Cytarabine |
Colon adenocarcinoma |
0.046541653 |
Resistant |
| ENSG00000272250.1 |
Cytarabine |
Colon adenocarcinoma |
0.01817475 |
Resistant |
| ENSG00000272265.1 |
Cytarabine |
Colon adenocarcinoma |
0.022517598 |
Resistant |
| ENSG00000272312.1 |
Cytarabine |
Colon adenocarcinoma |
0.04579495 |
Resistant |
| ENSG00000272849.1 |
Cytarabine |
Colon adenocarcinoma |
0.043539042 |
Resistant |
| ENSG00000273001.1 |
Cytarabine |
Colon adenocarcinoma |
0.027856765 |
Resistant |
| ENSG00000273096.1 |
Cytarabine |
Colon adenocarcinoma |
0.009915441 |
Resistant |
| ENSG00000273143.1 |
Cytarabine |
Colon adenocarcinoma |
0.041345617 |
Resistant |
| ENSG00000273156.1 |
Cytarabine |
Colon adenocarcinoma |
0.02210424 |
Resistant |
| ENSG00000273165.1 |
Cytarabine |
Colon adenocarcinoma |
0.045865203 |
Resistant |
| ENSG00000177337.3 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014904153 |
Resistant |
| ENSG00000203327.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040681688 |
Resistant |
| ENSG00000206337.6 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013244828 |
Resistant |
| ENSG00000212978.5 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007105653 |
Resistant |
| ENSG00000213963.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02101441 |
Resistant |
| ENSG00000214432.5 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043092004 |
Resistant |
| ENSG00000215068.3 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040033169 |
Resistant |
| ENSG00000224616.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030416998 |
Resistant |
| ENSG00000225265.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049855931 |
Resistant |
| ENSG00000225506.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013526878 |
Resistant |
| ENSG00000226754.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005830758 |
Resistant |
| ENSG00000226853.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035891076 |
Resistant |
| ENSG00000227492.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005945981 |
Resistant |
| ENSG00000228686.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018293591 |
Resistant |
| ENSG00000228852.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034587281 |
Resistant |
| ENSG00000229487.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0061857 |
Resistant |
| ENSG00000230433.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039353929 |
Resistant |
| ENSG00000230925.3 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01149907 |
Resistant |
| ENSG00000232295.3 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017048164 |
Resistant |
| ENSG00000232860.3 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029745476 |
Resistant |
| ENSG00000233080.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039329228 |
Resistant |
| ENSG00000233847.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001951157 |
Resistant |
| ENSG00000234006.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044572368 |
Resistant |
| ENSG00000234230.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035445031 |
Resistant |
| ENSG00000237998.3 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012313002 |
Resistant |
| ENSG00000238197.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019576315 |
Resistant |
| ENSG00000239828.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018846047 |
Resistant |
| ENSG00000241014.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002126188 |
Resistant |
| ENSG00000241490.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037627915 |
Resistant |
| ENSG00000243485.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042367336 |
Resistant |
| ENSG00000245060.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037598844 |
Resistant |
| ENSG00000245571.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032629921 |
Resistant |
| ENSG00000246130.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011921585 |
Resistant |
| ENSG00000247134.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026048368 |
Resistant |
| ENSG00000247950.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002719049 |
Resistant |
| ENSG00000248240.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0240666 |
Resistant |
| ENSG00000249791.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020258232 |
Resistant |
| ENSG00000250033.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007762936 |
Resistant |
| ENSG00000250616.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042033178 |
Resistant |
| ENSG00000251023.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042731603 |
Resistant |
| ENSG00000251141.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041089036 |
Resistant |
| ENSG00000251602.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035908963 |
Resistant |
| ENSG00000253327.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037312648 |
Resistant |
| ENSG00000253476.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027250165 |
Resistant |
| ENSG00000253893.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015845299 |
Resistant |
| ENSG00000254295.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046113868 |
Resistant |
| ENSG00000254459.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011087244 |
Resistant |
| ENSG00000254860.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015320694 |
Resistant |
| ENSG00000255507.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039023319 |
Resistant |
| ENSG00000258268.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043190706 |
Resistant |
| ENSG00000258821.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049987709 |
Resistant |
| ENSG00000258891.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04256198 |
Resistant |
| ENSG00000258949.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022210333 |
Resistant |
| ENSG00000259088.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029714817 |
Resistant |
| ENSG00000259153.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030732699 |
Resistant |
| ENSG00000259442.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047863628 |
Resistant |
| ENSG00000259628.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025001355 |
Resistant |
| ENSG00000259921.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01586558 |
Resistant |
| ENSG00000260613.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038949627 |
Resistant |
| ENSG00000260912.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024842917 |
Resistant |
| ENSG00000261286.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036952234 |
Resistant |
| ENSG00000261329.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038891891 |
Resistant |
| ENSG00000262001.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019366594 |
Resistant |
| ENSG00000262482.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024660205 |
Resistant |
| ENSG00000263280.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043147049 |
Resistant |
| ENSG00000264940.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049051391 |
Resistant |
| ENSG00000265778.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032733718 |
Resistant |
| ENSG00000266261.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040492632 |
Resistant |
| ENSG00000266473.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022450766 |
Resistant |
| ENSG00000266904.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015819646 |
Resistant |
| ENSG00000267581.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020708459 |
Resistant |
| ENSG00000267715.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048581899 |
Resistant |
| ENSG00000269560.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036995943 |
Resistant |
| ENSG00000269896.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04639419 |
Resistant |
| ENSG00000269983.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031334048 |
Resistant |
| ENSG00000271996.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037636021 |
Resistant |
| ENSG00000272033.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029367036 |
Resistant |
| ENSG00000272065.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0312298 |
Resistant |
| ENSG00000272109.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041566267 |
Resistant |
| ENSG00000272144.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037246132 |
Resistant |
| ENSG00000272146.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020149144 |
Resistant |
| ENSG00000272148.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002813812 |
Resistant |
| ENSG00000272183.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049014112 |
Resistant |
| ENSG00000272354.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047957734 |
Resistant |
| ENSG00000272970.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019487887 |
Resistant |
| ENSG00000272983.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000659284 |
Resistant |
| ENSG00000273007.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043183197 |
Resistant |
| ENSG00000273245.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048052165 |
Resistant |
| ENSG00000203362.2 |
Cytarabine |
Esophageal cancer |
0.013254515 |
Resistant |
| ENSG00000223478.1 |
Cytarabine |
Esophageal cancer |
0.009445987 |
Resistant |
| ENSG00000228265.1 |
Cytarabine |
Esophageal cancer |
0.004729471 |
Resistant |
| ENSG00000228386.2 |
Cytarabine |
Esophageal cancer |
0.019643019 |
Resistant |
| ENSG00000228598.1 |
Cytarabine |
Esophageal cancer |
0.042261221 |
Resistant |
| ENSG00000233695.1 |
Cytarabine |
Esophageal cancer |
0.004922514 |
Resistant |
| ENSG00000234230.1 |
Cytarabine |
Esophageal cancer |
0.027034222 |
Resistant |
| ENSG00000235262.1 |
Cytarabine |
Esophageal cancer |
0.038042615 |
Resistant |
| ENSG00000235659.1 |
Cytarabine |
Esophageal cancer |
0.042550643 |
Resistant |
| ENSG00000237523.1 |
Cytarabine |
Esophageal cancer |
0.037104204 |
Resistant |
| ENSG00000242553.1 |
Cytarabine |
Esophageal cancer |
0.022794229 |
Resistant |
| ENSG00000248599.1 |
Cytarabine |
Esophageal cancer |
0.001241018 |
Resistant |
| ENSG00000254263.1 |
Cytarabine |
Esophageal cancer |
0.030037171 |
Resistant |
| ENSG00000254862.1 |
Cytarabine |
Esophageal cancer |
0.010267983 |
Resistant |
| ENSG00000256050.2 |
Cytarabine |
Esophageal cancer |
0.025123289 |
Resistant |
| ENSG00000258044.1 |
Cytarabine |
Esophageal cancer |
0.032890694 |
Resistant |
| ENSG00000258858.1 |
Cytarabine |
Esophageal cancer |
0.045324901 |
Resistant |
| ENSG00000261024.2 |
Cytarabine |
Esophageal cancer |
0.013739849 |
Resistant |
| ENSG00000264769.1 |
Cytarabine |
Esophageal cancer |
0.042752333 |
Resistant |
| ENSG00000266088.1 |
Cytarabine |
Esophageal cancer |
0.037607359 |
Resistant |
| ENSG00000267342.1 |
Cytarabine |
Esophageal cancer |
0.034055775 |
Resistant |
| ENSG00000272370.1 |
Cytarabine |
Esophageal cancer |
0.001892581 |
Resistant |
| ENSG00000273311.1 |
Cytarabine |
Esophageal cancer |
0.016809766 |
Resistant |
| ENSG00000145063.10 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.028668491 |
Resistant |
| ENSG00000174365.15 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.000268144 |
Resistant |
| ENSG00000178947.8 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.026676461 |
Resistant |
| ENSG00000182648.7 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.001501474 |
Resistant |
| ENSG00000214733.4 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.009520805 |
Resistant |
| ENSG00000214955.5 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.016934109 |
Resistant |
| ENSG00000215859.4 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.037491054 |
Resistant |
| ENSG00000215863.2 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.029088292 |
Resistant |
| ENSG00000220161.4 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.036681133 |
Resistant |
| ENSG00000223387.2 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.003187923 |
Resistant |
| ENSG00000223799.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.000754546 |
Resistant |
| ENSG00000224481.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.01734025 |
Resistant |
| ENSG00000226155.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.042480834 |
Resistant |
| ENSG00000226637.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.019922407 |
Resistant |
| ENSG00000228372.3 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.048611329 |
Resistant |
| ENSG00000228395.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.040286202 |
Resistant |
| ENSG00000228824.2 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.030678077 |
Resistant |
| ENSG00000228956.4 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.031404234 |
Resistant |
| ENSG00000229521.2 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.029284364 |
Resistant |
| ENSG00000229951.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.019037419 |
Resistant |
| ENSG00000230366.5 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.03285288 |
Resistant |
| ENSG00000230479.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.033193129 |
Resistant |
| ENSG00000233223.2 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.039929261 |
Resistant |
| ENSG00000233429.5 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.038537098 |
Resistant |
| ENSG00000233818.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.001433777 |
Resistant |
| ENSG00000234062.3 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.03521778 |
Resistant |
| ENSG00000234235.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.032828064 |
Resistant |
| ENSG00000234705.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.047797627 |
Resistant |
| ENSG00000234869.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.005150333 |
Resistant |
| ENSG00000235609.4 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.015084767 |
Resistant |
| ENSG00000236256.5 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.045215572 |
Resistant |
| ENSG00000236514.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.011423702 |
Resistant |
| ENSG00000238039.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.002345582 |
Resistant |
| ENSG00000241954.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.004141935 |
Resistant |
| ENSG00000242808.3 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.01216895 |
Resistant |
| ENSG00000245552.2 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.004605419 |
Resistant |
| ENSG00000248323.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.001341285 |
Resistant |
| ENSG00000248932.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.030019488 |
Resistant |
| ENSG00000248936.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.045927195 |
Resistant |
| ENSG00000249609.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.002202991 |
Resistant |
| ENSG00000249859.3 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.017089803 |
Resistant |
| ENSG00000250075.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.019124994 |
Resistant |
| ENSG00000250842.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.026136754 |
Resistant |
| ENSG00000251136.4 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.045913435 |
Resistant |
| ENSG00000251143.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.018468951 |
Resistant |
| ENSG00000251179.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.011902391 |
Resistant |
| ENSG00000254837.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.042370679 |
Resistant |
| ENSG00000254872.2 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.011631625 |
Resistant |
| ENSG00000254910.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.015878933 |
Resistant |
| ENSG00000256789.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.034862118 |
Resistant |
| ENSG00000257556.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.007842377 |
Resistant |
| ENSG00000257880.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.042485773 |
Resistant |
| ENSG00000259327.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.029992877 |
Resistant |
| ENSG00000259933.2 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.008739925 |
Resistant |
| ENSG00000259942.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.033349092 |
Resistant |
| ENSG00000260949.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.016944793 |
Resistant |
| ENSG00000261000.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.038235912 |
Resistant |
| ENSG00000261360.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.019912194 |
Resistant |
| ENSG00000261662.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.027159137 |
Resistant |
| ENSG00000261744.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.004917766 |
Resistant |
| ENSG00000262454.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.044674772 |
Resistant |
| ENSG00000262979.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.017815283 |
Resistant |
| ENSG00000264222.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.032916773 |
Resistant |
| ENSG00000265542.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.019799241 |
Resistant |
| ENSG00000267405.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.049946178 |
Resistant |
| ENSG00000269487.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.038914073 |
Resistant |
| ENSG00000270035.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.028239388 |
Resistant |
| ENSG00000270332.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.044185785 |
Resistant |
| ENSG00000270346.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.01241734 |
Resistant |
| ENSG00000270426.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.030234634 |
Resistant |
| ENSG00000271200.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.041446738 |
Resistant |
| ENSG00000271762.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.002578974 |
Resistant |
| ENSG00000271826.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.027660475 |
Resistant |
| ENSG00000271874.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.025291479 |
Resistant |
| ENSG00000272086.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.0055491 |
Resistant |
| ENSG00000272755.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.029741078 |
Resistant |
| ENSG00000272864.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.016143363 |
Resistant |
| ENSG00000273148.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.026219407 |
Resistant |
| ENSG00000182873.4 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.015808068 |
Resistant |
| ENSG00000184274.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.026269057 |
Resistant |
| ENSG00000185044.10 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.035781838 |
Resistant |
| ENSG00000197558.7 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.004821679 |
Resistant |
| ENSG00000203327.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.03678515 |
Resistant |
| ENSG00000204054.7 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.005480025 |
Resistant |
| ENSG00000205559.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.042960606 |
Resistant |
| ENSG00000223576.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.042575548 |
Resistant |
| ENSG00000225235.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.025666404 |
Resistant |
| ENSG00000225278.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.043351752 |
Resistant |
| ENSG00000225872.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.033936745 |
Resistant |
| ENSG00000226179.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.034358684 |
Resistant |
| ENSG00000226312.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.023664632 |
Resistant |
| ENSG00000227484.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.017069383 |
Resistant |
| ENSG00000228109.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.045708098 |
Resistant |
| ENSG00000228140.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.035767456 |
Resistant |
| ENSG00000228889.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.04813188 |
Resistant |
| ENSG00000229162.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.008717203 |
Resistant |
| ENSG00000229278.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.00011253 |
Resistant |
| ENSG00000229780.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.015892618 |
Resistant |
| ENSG00000229841.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.045792834 |
Resistant |
| ENSG00000230881.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.013180895 |
Resistant |
| ENSG00000231113.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.041410995 |
Resistant |
| ENSG00000231212.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.046427514 |
Resistant |
| ENSG00000231298.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.006559992 |
Resistant |
| ENSG00000231346.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.008121858 |
Resistant |
| ENSG00000233654.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.012803139 |
Resistant |
| ENSG00000233665.4 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.031179514 |
Resistant |
| ENSG00000234650.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.014012649 |
Resistant |
| ENSG00000234678.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.045088136 |
Resistant |
| ENSG00000234869.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.031507133 |
Resistant |
| ENSG00000235888.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.010087811 |
Resistant |
| ENSG00000236472.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.034666886 |
Resistant |
| ENSG00000237331.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.011373791 |
Resistant |
| ENSG00000237576.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.00256527 |
Resistant |
| ENSG00000238039.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.047220543 |
Resistant |
| ENSG00000238261.5 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.023935611 |
Resistant |
| ENSG00000239353.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.047387809 |
Resistant |
| ENSG00000241990.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.034083726 |
Resistant |
| ENSG00000245928.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.025641577 |
Resistant |
| ENSG00000247595.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.003846968 |
Resistant |
| ENSG00000248187.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.022827825 |
Resistant |
| ENSG00000248846.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.01597065 |
Resistant |
| ENSG00000250948.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.044930189 |
Resistant |
| ENSG00000253187.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.028409352 |
Resistant |
| ENSG00000253730.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.000358916 |
Resistant |
| ENSG00000253837.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.037217143 |
Resistant |
| ENSG00000254207.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.023403109 |
Resistant |
| ENSG00000254473.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.007558329 |
Resistant |
| ENSG00000255142.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.007304967 |
Resistant |
| ENSG00000258172.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.002464111 |
Resistant |
| ENSG00000258689.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.013695603 |
Resistant |
| ENSG00000258730.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.005127731 |
Resistant |
| ENSG00000259188.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.042620259 |
Resistant |
| ENSG00000259448.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.007483361 |
Resistant |
| ENSG00000259772.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.025591945 |
Resistant |
| ENSG00000259807.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.028889398 |
Resistant |
| ENSG00000260052.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.004574079 |
Resistant |
| ENSG00000260063.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.021662462 |
Resistant |
| ENSG00000260136.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.000958295 |
Resistant |
| ENSG00000260487.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.013154616 |
Resistant |
| ENSG00000260929.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.000154676 |
Resistant |
| ENSG00000261269.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.025872511 |
Resistant |
| ENSG00000261442.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.026909132 |
Resistant |
| ENSG00000261451.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.029630528 |
Resistant |
| ENSG00000261523.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.020771084 |
Resistant |
| ENSG00000261671.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.040611043 |
Resistant |
| ENSG00000262061.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.003667144 |
Resistant |
| ENSG00000264769.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.033999978 |
Resistant |
| ENSG00000265055.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.009873397 |
Resistant |
| ENSG00000265743.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.03494727 |
Resistant |
| ENSG00000266921.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.000791369 |
Resistant |
| ENSG00000267089.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.010735827 |
Resistant |
| ENSG00000267480.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.003248749 |
Resistant |
| ENSG00000267638.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.024354644 |
Resistant |
| ENSG00000268204.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.01274528 |
Resistant |
| ENSG00000268756.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.00843105 |
Resistant |
| ENSG00000269161.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.026368289 |
Resistant |
| ENSG00000269892.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.01206231 |
Resistant |
| ENSG00000270154.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.009670296 |
Resistant |
| ENSG00000271631.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.015053685 |
Resistant |
| ENSG00000272183.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.003108186 |
Resistant |
| ENSG00000272902.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.006886667 |
Resistant |
| ENSG00000272908.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.038531602 |
Resistant |
| ENSG00000273018.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.002161107 |
Resistant |
| ENSG00000273186.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.031537461 |
Resistant |
| ENSG00000273248.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.034782357 |
Resistant |
| ENSG00000273289.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.001404467 |
Resistant |
| ENSG00000180139.10 |
Cytarabine |
Brain lower grade glioma |
0.027478665 |
Resistant |
| ENSG00000189196.4 |
Cytarabine |
Brain lower grade glioma |
0.049481283 |
Resistant |
| ENSG00000203801.4 |
Cytarabine |
Brain lower grade glioma |
0.037820331 |
Resistant |
| ENSG00000223979.2 |
Cytarabine |
Brain lower grade glioma |
0.030236908 |
Resistant |
| ENSG00000224871.1 |
Cytarabine |
Brain lower grade glioma |
0.024687548 |
Resistant |
| ENSG00000225216.2 |
Cytarabine |
Brain lower grade glioma |
0.004409849 |
Resistant |
| ENSG00000226711.2 |
Cytarabine |
Brain lower grade glioma |
0.035392887 |
Resistant |
| ENSG00000226851.1 |
Cytarabine |
Brain lower grade glioma |
0.011074825 |
Resistant |
| ENSG00000228786.1 |
Cytarabine |
Brain lower grade glioma |
0.009059175 |
Resistant |
| ENSG00000230536.1 |
Cytarabine |
Brain lower grade glioma |
0.021070487 |
Resistant |
| ENSG00000231709.1 |
Cytarabine |
Brain lower grade glioma |
0.021371045 |
Resistant |
| ENSG00000232406.2 |
Cytarabine |
Brain lower grade glioma |
0.037373566 |
Resistant |
| ENSG00000232814.2 |
Cytarabine |
Brain lower grade glioma |
0.029294257 |
Resistant |
| ENSG00000234456.3 |
Cytarabine |
Brain lower grade glioma |
0.039040807 |
Resistant |
| ENSG00000234913.1 |
Cytarabine |
Brain lower grade glioma |
0.016116535 |
Resistant |
| ENSG00000237517.4 |
Cytarabine |
Brain lower grade glioma |
0.007155737 |
Resistant |
| ENSG00000237928.1 |
Cytarabine |
Brain lower grade glioma |
0.047666433 |
Resistant |
| ENSG00000239801.1 |
Cytarabine |
Brain lower grade glioma |
0.04221757 |
Resistant |
| ENSG00000245729.1 |
Cytarabine |
Brain lower grade glioma |
0.047003055 |
Resistant |
| ENSG00000246859.2 |
Cytarabine |
Brain lower grade glioma |
0.026342401 |
Resistant |
| ENSG00000249835.2 |
Cytarabine |
Brain lower grade glioma |
0.045729215 |
Resistant |
| ENSG00000251613.3 |
Cytarabine |
Brain lower grade glioma |
0.033233306 |
Resistant |
| ENSG00000253385.1 |
Cytarabine |
Brain lower grade glioma |
0.031224681 |
Resistant |
| ENSG00000253733.2 |
Cytarabine |
Brain lower grade glioma |
0.000619499 |
Resistant |
| ENSG00000256603.1 |
Cytarabine |
Brain lower grade glioma |
0.03847683 |
Resistant |
| ENSG00000259888.1 |
Cytarabine |
Brain lower grade glioma |
0.023388583 |
Resistant |
| ENSG00000259969.1 |
Cytarabine |
Brain lower grade glioma |
0.041379922 |
Resistant |
| ENSG00000260931.1 |
Cytarabine |
Brain lower grade glioma |
0.031545144 |
Resistant |
| ENSG00000261291.1 |
Cytarabine |
Brain lower grade glioma |
0.008895386 |
Resistant |
| ENSG00000261827.1 |
Cytarabine |
Brain lower grade glioma |
0.043116069 |
Resistant |
| ENSG00000262265.1 |
Cytarabine |
Brain lower grade glioma |
0.007803791 |
Resistant |
| ENSG00000263924.1 |
Cytarabine |
Brain lower grade glioma |
0.045982596 |
Resistant |
| ENSG00000267273.1 |
Cytarabine |
Brain lower grade glioma |
0.030065335 |
Resistant |
| ENSG00000267366.1 |
Cytarabine |
Brain lower grade glioma |
0.038873354 |
Resistant |
| ENSG00000267734.1 |
Cytarabine |
Brain lower grade glioma |
0.022524421 |
Resistant |
| ENSG00000269950.1 |
Cytarabine |
Brain lower grade glioma |
0.009405418 |
Resistant |
| ENSG00000270022.2 |
Cytarabine |
Brain lower grade glioma |
0.003752847 |
Resistant |
| ENSG00000270883.1 |
Cytarabine |
Brain lower grade glioma |
0.032000468 |
Resistant |
| ENSG00000271993.1 |
Cytarabine |
Brain lower grade glioma |
0.025119588 |
Resistant |
| ENSG00000272374.1 |
Cytarabine |
Brain lower grade glioma |
0.035850625 |
Resistant |
| ENSG00000272542.1 |
Cytarabine |
Brain lower grade glioma |
0.02645652 |
Resistant |
| ENSG00000272691.1 |
Cytarabine |
Brain lower grade glioma |
0.045647116 |
Resistant |
| ENSG00000272746.1 |
Cytarabine |
Brain lower grade glioma |
0.03816694 |
Resistant |
| ENSG00000272815.1 |
Cytarabine |
Brain lower grade glioma |
0.043896657 |
Resistant |
| ENSG00000272832.1 |
Cytarabine |
Brain lower grade glioma |
0.049450339 |
Resistant |
| ENSG00000272905.1 |
Cytarabine |
Brain lower grade glioma |
0.047394796 |
Resistant |
| ENSG00000272966.1 |
Cytarabine |
Brain lower grade glioma |
0.01981163 |
Resistant |
| ENSG00000273270.1 |
Cytarabine |
Brain lower grade glioma |
0.008918885 |
Resistant |
| ENSG00000170161.6 |
Cytarabine |
Lung squamous cell carcinoma |
0.045857122 |
Resistant |
| ENSG00000175611.7 |
Cytarabine |
Lung squamous cell carcinoma |
0.005414645 |
Resistant |
| ENSG00000185168.5 |
Cytarabine |
Lung squamous cell carcinoma |
0.049854514 |
Resistant |
| ENSG00000187979.4 |
Cytarabine |
Lung squamous cell carcinoma |
0.027975205 |
Resistant |
| ENSG00000198106.7 |
Cytarabine |
Lung squamous cell carcinoma |
0.049428821 |
Resistant |
| ENSG00000203280.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.01425228 |
Resistant |
| ENSG00000203497.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.005170145 |
Resistant |
| ENSG00000205634.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.028477238 |
Resistant |
| ENSG00000206028.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.042020681 |
Resistant |
| ENSG00000212694.4 |
Cytarabine |
Lung squamous cell carcinoma |
0.018698033 |
Resistant |
| ENSG00000214650.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.007016334 |
Resistant |
| ENSG00000214770.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.039449882 |
Resistant |
| ENSG00000214955.5 |
Cytarabine |
Lung squamous cell carcinoma |
0.007794554 |
Resistant |
| ENSG00000223678.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.042408142 |
Resistant |
| ENSG00000224046.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.001954074 |
Resistant |
| ENSG00000224086.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.04997968 |
Resistant |
| ENSG00000224220.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.007359066 |
Resistant |
| ENSG00000224541.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.003386147 |
Resistant |
| ENSG00000224614.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.019327047 |
Resistant |
| ENSG00000224616.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.009624938 |
Resistant |
| ENSG00000224804.4 |
Cytarabine |
Lung squamous cell carcinoma |
0.027489678 |
Resistant |
| ENSG00000224885.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025313915 |
Resistant |
| ENSG00000224995.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.0377445 |
Resistant |
| ENSG00000225057.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.025149516 |
Resistant |
| ENSG00000225235.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025056559 |
Resistant |
| ENSG00000225335.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.001232843 |
Resistant |
| ENSG00000225446.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.044113455 |
Resistant |
| ENSG00000225783.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.042988008 |
Resistant |
| ENSG00000225891.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.004688966 |
Resistant |
| ENSG00000226007.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.034905251 |
Resistant |
| ENSG00000226383.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.020918555 |
Resistant |
| ENSG00000226453.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.029196415 |
Resistant |
| ENSG00000226454.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.047510796 |
Resistant |
| ENSG00000226648.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.002627775 |
Resistant |
| ENSG00000226690.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.044508748 |
Resistant |
| ENSG00000226746.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.044780854 |
Resistant |
| ENSG00000226756.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.006934211 |
Resistant |
| ENSG00000226786.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.031119751 |
Resistant |
| ENSG00000226819.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.048098617 |
Resistant |
| ENSG00000226852.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.034811509 |
Resistant |
| ENSG00000226913.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.015566136 |
Resistant |
| ENSG00000227116.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.023422871 |
Resistant |
| ENSG00000227172.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.031275806 |
Resistant |
| ENSG00000227527.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.016369214 |
Resistant |
| ENSG00000227704.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.02658671 |
Resistant |
| ENSG00000227848.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.001499507 |
Resistant |
| ENSG00000228016.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.038240251 |
Resistant |
| ENSG00000228067.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.004508712 |
Resistant |
| ENSG00000228072.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.045677029 |
Resistant |
| ENSG00000228084.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.001401502 |
Resistant |
| ENSG00000228141.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.043528929 |
Resistant |
| ENSG00000228201.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.046114968 |
Resistant |
| ENSG00000228274.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.018012206 |
Resistant |
| ENSG00000228397.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034265179 |
Resistant |
| ENSG00000228412.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.013974728 |
Resistant |
| ENSG00000228487.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.030922252 |
Resistant |
| ENSG00000228566.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.044312971 |
Resistant |
| ENSG00000229065.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.038765442 |
Resistant |
| ENSG00000229243.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.048997958 |
Resistant |
| ENSG00000229463.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.045726273 |
Resistant |
| ENSG00000229498.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.011141872 |
Resistant |
| ENSG00000229766.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.014678033 |
Resistant |
| ENSG00000229970.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.01117087 |
Resistant |
| ENSG00000230366.5 |
Cytarabine |
Lung squamous cell carcinoma |
0.01961775 |
Resistant |
| ENSG00000230401.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.024980573 |
Resistant |
| ENSG00000230432.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.036221682 |
Resistant |
| ENSG00000230513.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.003951244 |
Resistant |
| ENSG00000230523.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.048521343 |
Resistant |
| ENSG00000230613.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034964511 |
Resistant |
| ENSG00000230679.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.016225589 |
Resistant |
| ENSG00000231217.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.032149727 |
Resistant |
| ENSG00000231327.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.008413595 |
Resistant |
| ENSG00000231636.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.01937542 |
Resistant |
| ENSG00000231742.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.039153563 |
Resistant |
| ENSG00000231795.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.043861642 |
Resistant |
| ENSG00000231806.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.036153728 |
Resistant |
| ENSG00000231944.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.046057098 |
Resistant |
| ENSG00000232057.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.037539999 |
Resistant |
| ENSG00000232104.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.028001351 |
Resistant |
| ENSG00000232412.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.02903678 |
Resistant |
| ENSG00000232461.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.045614116 |
Resistant |
| ENSG00000232504.4 |
Cytarabine |
Lung squamous cell carcinoma |
0.04337741 |
Resistant |
| ENSG00000232613.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.009156913 |
Resistant |
| ENSG00000232640.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.02339366 |
Resistant |
| ENSG00000232645.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.022652882 |
Resistant |
| ENSG00000233056.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.028822325 |
Resistant |
| ENSG00000233061.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.029202426 |
Resistant |
| ENSG00000233073.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.033326894 |
Resistant |
| ENSG00000233143.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.024476722 |
Resistant |
| ENSG00000233220.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.005842589 |
Resistant |
| ENSG00000233246.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.019697293 |
Resistant |
| ENSG00000233367.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.048973437 |
Resistant |
| ENSG00000233427.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.0320689 |
Resistant |
| ENSG00000233478.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.042173498 |
Resistant |
| ENSG00000233515.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.018817192 |
Resistant |
| ENSG00000233540.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034292691 |
Resistant |
| ENSG00000233860.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.027785684 |
Resistant |
| ENSG00000233862.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.030623571 |
Resistant |
| ENSG00000234006.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025181374 |
Resistant |
| ENSG00000234035.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.043676238 |
Resistant |
| ENSG00000234255.4 |
Cytarabine |
Lung squamous cell carcinoma |
0.048383181 |
Resistant |
| ENSG00000234396.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.013562996 |
Resistant |
| ENSG00000234445.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.049520962 |
Resistant |
| ENSG00000234630.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.012355603 |
Resistant |
| ENSG00000234676.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.005652521 |
Resistant |
| ENSG00000234884.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.018513461 |
Resistant |
| ENSG00000234917.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034296545 |
Resistant |
| ENSG00000234936.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.02502871 |
Resistant |
| ENSG00000235159.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.011945247 |
Resistant |
| ENSG00000235214.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.022389751 |
Resistant |
| ENSG00000235326.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.046635056 |
Resistant |
| ENSG00000235358.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.0101969 |
Resistant |
| ENSG00000235366.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.031654637 |
Resistant |
| ENSG00000235494.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.043223617 |
Resistant |
| ENSG00000235501.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.04139736 |
Resistant |
| ENSG00000235545.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.00744213 |
Resistant |
| ENSG00000235560.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.017627188 |
Resistant |
| ENSG00000237152.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.023654108 |
Resistant |
| ENSG00000237341.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025994402 |
Resistant |
| ENSG00000237404.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.004729224 |
Resistant |
| ENSG00000237750.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.048600993 |
Resistant |
| ENSG00000237853.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.030885788 |
Resistant |
| ENSG00000237950.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.011798264 |
Resistant |
| ENSG00000238113.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.040694206 |
Resistant |
| ENSG00000238140.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.00237243 |
Resistant |
| ENSG00000238141.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.028878435 |
Resistant |
| ENSG00000238197.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.011274837 |
Resistant |
| ENSG00000241818.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.011464049 |
Resistant |
| ENSG00000241832.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.040304892 |
Resistant |
| ENSG00000242770.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.043336075 |
Resistant |
| ENSG00000243485.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.027130958 |
Resistant |
| ENSG00000243810.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025193968 |
Resistant |
| ENSG00000244137.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034198481 |
Resistant |
| ENSG00000244184.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.01148111 |
Resistant |
| ENSG00000244332.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.048232008 |
Resistant |
| ENSG00000244383.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034095096 |
Resistant |
| ENSG00000244625.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.032564943 |
Resistant |
| ENSG00000244952.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.003375955 |
Resistant |
| ENSG00000245685.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.031700568 |
Resistant |
| ENSG00000245975.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.03920587 |
Resistant |
| ENSG00000246067.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.000832141 |
Resistant |
| ENSG00000246339.4 |
Cytarabine |
Lung squamous cell carcinoma |
0.036868134 |
Resistant |
| ENSG00000246792.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.038671776 |
Resistant |
| ENSG00000247400.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.006707746 |
Resistant |
| ENSG00000248103.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.032377149 |
Resistant |
| ENSG00000248238.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.018498527 |
Resistant |
| ENSG00000248245.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.041712553 |
Resistant |
| ENSG00000248367.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.035081381 |
Resistant |
| ENSG00000248515.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.016750686 |
Resistant |
| ENSG00000249234.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.049138879 |
Resistant |
| ENSG00000249593.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.011204343 |
Resistant |
| ENSG00000249595.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.014189613 |
Resistant |
| ENSG00000249650.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.019563965 |
Resistant |
| ENSG00000249717.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.011136709 |
Resistant |
| ENSG00000250012.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.039029501 |
Resistant |
| ENSG00000250596.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.0093079 |
Resistant |
| ENSG00000250802.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.034855828 |
Resistant |
| ENSG00000251072.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.014177423 |
Resistant |
| ENSG00000251161.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.025787942 |
Resistant |
| ENSG00000251301.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.001895092 |
Resistant |
| ENSG00000251331.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.033899262 |
Resistant |
| ENSG00000251408.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.026300273 |
Resistant |
| ENSG00000251666.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.016386946 |
Resistant |
| ENSG00000253197.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.00000251 |
Resistant |
| ENSG00000253576.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.049157566 |
Resistant |
| ENSG00000253974.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.048260183 |
Resistant |
| ENSG00000254044.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034751282 |
Resistant |
| ENSG00000254224.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.027336038 |
Resistant |
| ENSG00000254343.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.012752409 |
Resistant |
| ENSG00000254427.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.045068027 |
Resistant |
| ENSG00000254484.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.046836897 |
Resistant |
| ENSG00000254864.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.039555304 |
Resistant |
| ENSG00000254869.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.015355187 |
Resistant |
| ENSG00000255136.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.049886383 |
Resistant |
| ENSG00000255153.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.001110286 |
Resistant |
| ENSG00000255289.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.04229782 |
Resistant |
| ENSG00000255435.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.003652111 |
Resistant |
| ENSG00000255503.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.000802142 |
Resistant |
| ENSG00000255568.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.001317179 |
Resistant |
| ENSG00000255580.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.046199003 |
Resistant |
| ENSG00000256116.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.006467605 |
Resistant |
| ENSG00000256150.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.024183077 |
Resistant |
| ENSG00000256443.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.022763183 |
Resistant |
| ENSG00000256884.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025095136 |
Resistant |
| ENSG00000257052.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025437704 |
Resistant |
| ENSG00000257438.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.038022743 |
Resistant |
| ENSG00000257449.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.008779007 |
Resistant |
| ENSG00000257696.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.014540697 |
Resistant |
| ENSG00000257761.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.037519823 |
Resistant |
| ENSG00000257809.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.029207218 |
Resistant |
| ENSG00000257880.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.036103637 |
Resistant |
| ENSG00000258171.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.01193148 |
Resistant |
| ENSG00000258414.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.040995274 |
Resistant |
| ENSG00000258612.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.043488791 |
Resistant |
| ENSG00000258843.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.035472745 |
Resistant |
| ENSG00000258982.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.024938929 |
Resistant |
| ENSG00000259055.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.019893878 |
Resistant |
| ENSG00000259172.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.00764268 |
Resistant |
| ENSG00000259215.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.031768316 |
Resistant |
| ENSG00000259248.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.013423228 |
Resistant |
| ENSG00000259251.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.029762554 |
Resistant |
| ENSG00000259254.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.017581236 |
Resistant |
| ENSG00000259296.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.033393837 |
Resistant |
| ENSG00000259462.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.043869891 |
Resistant |
| ENSG00000259488.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.047674058 |
Resistant |
| ENSG00000259594.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.023830757 |
Resistant |
| ENSG00000259610.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.020406838 |
Resistant |
| ENSG00000259654.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.007400229 |
Resistant |
| ENSG00000259668.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.008563687 |
Resistant |
| ENSG00000259678.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.009318541 |
Resistant |
| ENSG00000259692.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.044418108 |
Resistant |
| ENSG00000259723.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.002815137 |
Resistant |
| ENSG00000259756.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.046277759 |
Resistant |
| ENSG00000259762.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.046464753 |
Resistant |
| ENSG00000259772.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.045317169 |
Resistant |
| ENSG00000259783.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.001699996 |
Resistant |
| ENSG00000259818.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.013184062 |
Resistant |
| ENSG00000259840.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.008651126 |
Resistant |
| ENSG00000259935.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.00537394 |
Resistant |
| ENSG00000260018.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.029651946 |
Resistant |
| ENSG00000260083.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.020925409 |
Resistant |
| ENSG00000260084.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.01296995 |
Resistant |
| ENSG00000260095.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.003108089 |
Resistant |
| ENSG00000260101.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.002167599 |
Resistant |
| ENSG00000260193.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.035417673 |
Resistant |
| ENSG00000260285.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.044516677 |
Resistant |
| ENSG00000260329.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.004170208 |
Resistant |
| ENSG00000260331.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.028631031 |
Resistant |
| ENSG00000260361.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.002021099 |
Resistant |
| ENSG00000260392.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.039281379 |
Resistant |
| ENSG00000260417.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.02450587 |
Resistant |
| ENSG00000260475.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.017995593 |
Resistant |
| ENSG00000260519.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.033743432 |
Resistant |
| ENSG00000260608.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.000960026 |
Resistant |
| ENSG00000260613.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.045726843 |
Resistant |
| ENSG00000260625.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.01464634 |
Resistant |
| ENSG00000260655.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.043676138 |
Resistant |
| ENSG00000260661.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.009167507 |
Resistant |
| ENSG00000260742.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.033223228 |
Resistant |
| ENSG00000260805.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.011255585 |
Resistant |
| ENSG00000260874.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.003251531 |
Resistant |
| ENSG00000260905.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.00868474 |
Resistant |
| ENSG00000260978.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.030406752 |
Resistant |
| ENSG00000260986.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.048879549 |
Resistant |
| ENSG00000261033.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.008472976 |
Resistant |
| ENSG00000261043.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.038397287 |
Resistant |
| ENSG00000261173.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.006100374 |
Resistant |
| ENSG00000261191.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.037537416 |
Resistant |
| ENSG00000261200.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.033681893 |
Resistant |
| ENSG00000261318.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.012576078 |
Resistant |
| ENSG00000261416.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.037043569 |
Resistant |
| ENSG00000261420.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.017271524 |
Resistant |
| ENSG00000261431.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.017994505 |
Resistant |
| ENSG00000261447.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.037867411 |
Resistant |
| ENSG00000261462.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.049013715 |
Resistant |
| ENSG00000261474.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.004379724 |
Resistant |
| ENSG00000261481.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.003373472 |
Resistant |
| ENSG00000261664.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.037950681 |
Resistant |
| ENSG00000261703.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.033665457 |
Resistant |
| ENSG00000261737.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.003832271 |
Resistant |
| ENSG00000261765.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.010620338 |
Resistant |
| ENSG00000262099.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.026570959 |
Resistant |
| ENSG00000262119.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.033311394 |
Resistant |
| ENSG00000262721.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.046348239 |
Resistant |
| ENSG00000262772.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.013215754 |
Resistant |
| ENSG00000262881.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.03600017 |
Resistant |
| ENSG00000263011.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.02497473 |
Resistant |
| ENSG00000263280.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.008352676 |
Resistant |
| ENSG00000263477.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.002157999 |
Resistant |
| ENSG00000263586.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.003456088 |
Resistant |
| ENSG00000264207.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.003791152 |
Resistant |
| ENSG00000264260.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.03784978 |
Resistant |
| ENSG00000264270.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.013758307 |
Resistant |
| ENSG00000264569.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.043898176 |
Resistant |
| ENSG00000265094.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.02897591 |
Resistant |
| ENSG00000265342.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.018352163 |
Resistant |
| ENSG00000266446.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.019018874 |
Resistant |
| ENSG00000266654.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025645184 |
Resistant |
| ENSG00000266677.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.016117128 |
Resistant |
| ENSG00000266934.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.019758309 |
Resistant |
| ENSG00000266955.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.042166301 |
Resistant |
| ENSG00000267024.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.043400965 |
Resistant |
| ENSG00000267172.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.030701113 |
Resistant |
| ENSG00000267212.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.006773857 |
Resistant |
| ENSG00000267231.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.041630648 |
Resistant |
| ENSG00000267262.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.049061124 |
Resistant |
| ENSG00000267289.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.006808755 |
Resistant |
| ENSG00000267299.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034619053 |
Resistant |
| ENSG00000267374.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.021746338 |
Resistant |
| ENSG00000267565.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.022224844 |
Resistant |
| ENSG00000267649.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.016762513 |
Resistant |
| ENSG00000267658.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.03030807 |
Resistant |
| ENSG00000267677.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.015293807 |
Resistant |
| ENSG00000268204.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.020353506 |
Resistant |
| ENSG00000268257.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.041165019 |
Resistant |
| ENSG00000268536.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.049991818 |
Resistant |
| ENSG00000268650.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.037902717 |
Resistant |
| ENSG00000269921.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.001699771 |
Resistant |
| ENSG00000270049.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.001365004 |
Resistant |
| ENSG00000270487.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.017152703 |
Resistant |
| ENSG00000270557.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.042493531 |
Resistant |
| ENSG00000270605.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.015692367 |
Resistant |
| ENSG00000270761.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.036346928 |
Resistant |
| ENSG00000270964.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.014122607 |
Resistant |
| ENSG00000271151.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.035617093 |
Resistant |
| ENSG00000271200.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.020418525 |
Resistant |
| ENSG00000271265.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.003472843 |
Resistant |
| ENSG00000271551.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.00327817 |
Resistant |
| ENSG00000271757.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.044733795 |
Resistant |
| ENSG00000271855.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.030394618 |
Resistant |
| ENSG00000271938.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.042930492 |
Resistant |
| ENSG00000271952.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.03162959 |
Resistant |
| ENSG00000271981.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.020985381 |
Resistant |
| ENSG00000272048.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.032194824 |
Resistant |
| ENSG00000272168.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.045319261 |
Resistant |
| ENSG00000272216.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.013080875 |
Resistant |
| ENSG00000272301.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.035006553 |
Resistant |
| ENSG00000272312.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.020837633 |
Resistant |
| ENSG00000272328.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.011008783 |
Resistant |
| ENSG00000272372.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.03346675 |
Resistant |
| ENSG00000272449.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.026953374 |
Resistant |
| ENSG00000272516.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.012006199 |
Resistant |
| ENSG00000272518.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034494923 |
Resistant |
| ENSG00000272524.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.016614663 |
Resistant |
| ENSG00000272657.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.008831654 |
Resistant |
| ENSG00000272677.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.030053745 |
Resistant |
| ENSG00000272682.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.016369554 |
Resistant |
| ENSG00000272717.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.01228765 |
Resistant |
| ENSG00000272721.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.047283001 |
Resistant |
| ENSG00000272735.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.017392943 |
Resistant |
| ENSG00000272798.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.019786699 |
Resistant |
| ENSG00000272829.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.004959467 |
Resistant |
| ENSG00000272849.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.023942568 |
Resistant |
| ENSG00000272931.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.024104764 |
Resistant |
| ENSG00000272940.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.037215831 |
Resistant |
| ENSG00000272942.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.038676965 |
Resistant |
| ENSG00000272954.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.007163761 |
Resistant |
| ENSG00000272984.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.047522908 |
Resistant |
| ENSG00000273009.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.031513437 |
Resistant |
| ENSG00000273061.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.022478489 |
Resistant |
| ENSG00000273084.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.029074197 |
Resistant |
| ENSG00000273091.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034049363 |
Resistant |
| ENSG00000273104.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.046546272 |
Resistant |
| ENSG00000273125.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.042947274 |
Resistant |
| ENSG00000273145.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.01429583 |
Resistant |
| ENSG00000273175.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.013253434 |
Resistant |
| ENSG00000273216.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.0379029 |
Resistant |
| ENSG00000273218.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.026091593 |
Resistant |
| ENSG00000273253.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.000895002 |
Resistant |
| ENSG00000273289.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.047517408 |
Resistant |
| ENSG00000273301.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.04217822 |
Resistant |
| ENSG00000273342.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.006957862 |
Resistant |
| ENSG00000273424.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.01233219 |
Resistant |
| ENSG00000273456.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.001524525 |
Resistant |
| ENSG00000178947.8 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040308425 |
Resistant |
| ENSG00000223522.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033540776 |
Resistant |
| ENSG00000226386.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036501635 |
Resistant |
| ENSG00000226754.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015982768 |
Resistant |
| ENSG00000226856.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049225123 |
Resistant |
| ENSG00000228288.2 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030987381 |
Resistant |
| ENSG00000232274.2 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04640022 |
Resistant |
| ENSG00000235246.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02755251 |
Resistant |
| ENSG00000236682.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025258958 |
Resistant |
| ENSG00000237133.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014202377 |
Resistant |
| ENSG00000253878.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020594347 |
Resistant |
| ENSG00000254718.2 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041445788 |
Resistant |
| ENSG00000257642.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023437245 |
Resistant |
| ENSG00000259623.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044335964 |
Resistant |
| ENSG00000259771.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023128414 |
Resistant |
| ENSG00000260830.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017752001 |
Resistant |
| ENSG00000266111.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043810924 |
Resistant |
| ENSG00000267265.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042289816 |
Resistant |
| ENSG00000267750.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013277516 |
Resistant |
| ENSG00000270659.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009665456 |
Resistant |
| ENSG00000271133.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032640885 |
Resistant |
| ENSG00000272871.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039601751 |
Resistant |
| ENSG00000171889.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.028670638 |
Resistant |
| ENSG00000225490.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.010806356 |
Resistant |
| ENSG00000226272.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.024686645 |
Resistant |
| ENSG00000227640.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.026564 |
Resistant |
| ENSG00000228386.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.008534847 |
Resistant |
| ENSG00000230010.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.047375254 |
Resistant |
| ENSG00000236256.5 |
Cytarabine |
Pancreatic adenocarcinoma |
0.044092141 |
Resistant |
| ENSG00000238039.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.018203483 |
Resistant |
| ENSG00000248100.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.032217422 |
Resistant |
| ENSG00000250508.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.018045607 |
Resistant |
| ENSG00000251059.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.048292217 |
Resistant |
| ENSG00000253582.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.027709154 |
Resistant |
| ENSG00000254153.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.004297774 |
Resistant |
| ENSG00000257671.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.025007371 |
Resistant |
| ENSG00000258412.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.03340803 |
Resistant |
| ENSG00000259115.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.041949018 |
Resistant |
| ENSG00000259450.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.04979901 |
Resistant |
| ENSG00000260507.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.011142347 |
Resistant |
| ENSG00000260833.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.032531109 |
Resistant |
| ENSG00000261295.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.028062039 |
Resistant |
| ENSG00000261760.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.040573426 |
Resistant |
| ENSG00000267151.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.024527532 |
Resistant |
| ENSG00000272328.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.032184833 |
Resistant |
| ENSG00000272933.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.019794844 |
Resistant |
| ENSG00000273108.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.034528085 |
Resistant |
| ENSG00000180279.5 |
Cytarabine |
Sarcoma |
0.031898384 |
Resistant |
| ENSG00000225798.1 |
Cytarabine |
Sarcoma |
0.034071759 |
Resistant |
| ENSG00000227438.1 |
Cytarabine |
Sarcoma |
0.033181315 |
Resistant |
| ENSG00000228495.1 |
Cytarabine |
Sarcoma |
0.049336734 |
Resistant |
| ENSG00000229137.2 |
Cytarabine |
Sarcoma |
0.044708256 |
Resistant |
| ENSG00000230561.3 |
Cytarabine |
Sarcoma |
0.017154194 |
Resistant |
| ENSG00000235426.2 |
Cytarabine |
Sarcoma |
0.00980218 |
Resistant |
| ENSG00000235790.3 |
Cytarabine |
Sarcoma |
0.015449375 |
Resistant |
| ENSG00000247311.2 |
Cytarabine |
Sarcoma |
0.039168107 |
Resistant |
| ENSG00000251615.3 |
Cytarabine |
Sarcoma |
0.039581037 |
Resistant |
| ENSG00000254275.2 |
Cytarabine |
Sarcoma |
0.028024286 |
Resistant |
| ENSG00000254554.1 |
Cytarabine |
Sarcoma |
0.035733782 |
Resistant |
| ENSG00000260841.1 |
Cytarabine |
Sarcoma |
0.027433435 |
Resistant |
| ENSG00000260947.1 |
Cytarabine |
Sarcoma |
0.004011432 |
Resistant |
| ENSG00000266304.1 |
Cytarabine |
Sarcoma |
0.014633742 |
Resistant |
| ENSG00000267322.1 |
Cytarabine |
Sarcoma |
0.030162909 |
Resistant |
| ENSG00000271522.1 |
Cytarabine |
Sarcoma |
0.039837916 |
Resistant |
| ENSG00000272905.1 |
Cytarabine |
Sarcoma |
0.035423696 |
Resistant |
| ENSG00000273464.1 |
Cytarabine |
Sarcoma |
0.007460095 |
Resistant |
| ENSG00000186148.7 |
Cytarabine |
Skin cutaneous melanoma |
0.026986629 |
Resistant |
| ENSG00000214650.2 |
Cytarabine |
Skin cutaneous melanoma |
0.046037593 |
Resistant |
| ENSG00000215458.4 |
Cytarabine |
Skin cutaneous melanoma |
0.037564384 |
Resistant |
| ENSG00000225353.2 |
Cytarabine |
Skin cutaneous melanoma |
0.000725946 |
Resistant |
| ENSG00000225498.1 |
Cytarabine |
Skin cutaneous melanoma |
0.040577392 |
Resistant |
| ENSG00000227719.1 |
Cytarabine |
Skin cutaneous melanoma |
0.0369128 |
Resistant |
| ENSG00000228013.1 |
Cytarabine |
Skin cutaneous melanoma |
0.023965437 |
Resistant |
| ENSG00000228222.1 |
Cytarabine |
Skin cutaneous melanoma |
0.025008753 |
Resistant |
| ENSG00000228577.1 |
Cytarabine |
Skin cutaneous melanoma |
0.016138403 |
Resistant |
| ENSG00000228705.1 |
Cytarabine |
Skin cutaneous melanoma |
0.033296332 |
Resistant |
| ENSG00000228786.1 |
Cytarabine |
Skin cutaneous melanoma |
0.019136939 |
Resistant |
| ENSG00000230005.2 |
Cytarabine |
Skin cutaneous melanoma |
0.035546529 |
Resistant |
| ENSG00000230433.1 |
Cytarabine |
Skin cutaneous melanoma |
0.027061391 |
Resistant |
| ENSG00000231422.2 |
Cytarabine |
Skin cutaneous melanoma |
0.038584113 |
Resistant |
| ENSG00000231527.1 |
Cytarabine |
Skin cutaneous melanoma |
0.000416896 |
Resistant |
| ENSG00000231728.2 |
Cytarabine |
Skin cutaneous melanoma |
0.040767563 |
Resistant |
| ENSG00000232912.1 |
Cytarabine |
Skin cutaneous melanoma |
0.040606572 |
Resistant |
| ENSG00000236230.1 |
Cytarabine |
Skin cutaneous melanoma |
0.027398327 |
Resistant |
| ENSG00000243144.2 |
Cytarabine |
Skin cutaneous melanoma |
0.047248262 |
Resistant |
| ENSG00000245534.2 |
Cytarabine |
Skin cutaneous melanoma |
0.015511225 |
Resistant |
| ENSG00000246130.1 |
Cytarabine |
Skin cutaneous melanoma |
0.039360167 |
Resistant |
| ENSG00000246225.2 |
Cytarabine |
Skin cutaneous melanoma |
0.016514774 |
Resistant |
| ENSG00000246250.2 |
Cytarabine |
Skin cutaneous melanoma |
0.026643396 |
Resistant |
| ENSG00000247199.3 |
Cytarabine |
Skin cutaneous melanoma |
0.02192635 |
Resistant |
| ENSG00000248771.1 |
Cytarabine |
Skin cutaneous melanoma |
0.029751083 |
Resistant |
| ENSG00000249602.1 |
Cytarabine |
Skin cutaneous melanoma |
0.044426068 |
Resistant |
| ENSG00000249609.1 |
Cytarabine |
Skin cutaneous melanoma |
0.042808073 |
Resistant |
| ENSG00000250286.1 |
Cytarabine |
Skin cutaneous melanoma |
0.005738234 |
Resistant |
| ENSG00000250343.1 |
Cytarabine |
Skin cutaneous melanoma |
0.011738512 |
Resistant |
| ENSG00000253174.2 |
Cytarabine |
Skin cutaneous melanoma |
0.044533999 |
Resistant |
| ENSG00000255145.1 |
Cytarabine |
Skin cutaneous melanoma |
0.031650916 |
Resistant |
| ENSG00000255241.1 |
Cytarabine |
Skin cutaneous melanoma |
0.041782516 |
Resistant |
| ENSG00000255487.1 |
Cytarabine |
Skin cutaneous melanoma |
0.018045653 |
Resistant |
| ENSG00000257052.1 |
Cytarabine |
Skin cutaneous melanoma |
0.010594175 |
Resistant |
| ENSG00000257551.1 |
Cytarabine |
Skin cutaneous melanoma |
0.027138018 |
Resistant |
| ENSG00000257947.1 |
Cytarabine |
Skin cutaneous melanoma |
0.041840362 |
Resistant |
| ENSG00000259584.1 |
Cytarabine |
Skin cutaneous melanoma |
0.032347724 |
Resistant |
| ENSG00000260011.2 |
Cytarabine |
Skin cutaneous melanoma |
0.035075373 |
Resistant |
| ENSG00000260834.1 |
Cytarabine |
Skin cutaneous melanoma |
0.039056382 |
Resistant |
| ENSG00000261026.1 |
Cytarabine |
Skin cutaneous melanoma |
0.015090055 |
Resistant |
| ENSG00000264546.1 |
Cytarabine |
Skin cutaneous melanoma |
0.008888267 |
Resistant |
| ENSG00000266079.2 |
Cytarabine |
Skin cutaneous melanoma |
0.037589529 |
Resistant |
| ENSG00000267197.1 |
Cytarabine |
Skin cutaneous melanoma |
0.049597974 |
Resistant |
| ENSG00000267549.1 |
Cytarabine |
Skin cutaneous melanoma |
0.030483553 |
Resistant |
| ENSG00000268095.1 |
Cytarabine |
Skin cutaneous melanoma |
0.032738351 |
Resistant |
| ENSG00000269487.1 |
Cytarabine |
Skin cutaneous melanoma |
0.042884892 |
Resistant |
| ENSG00000272273.1 |
Cytarabine |
Skin cutaneous melanoma |
0.023358789 |
Resistant |
| ENSG00000272346.1 |
Cytarabine |
Skin cutaneous melanoma |
0.018056895 |
Resistant |
| ENSG00000273097.1 |
Cytarabine |
Skin cutaneous melanoma |
0.046909793 |
Resistant |
| ENSG00000273309.1 |
Cytarabine |
Skin cutaneous melanoma |
0.003581688 |
Resistant |
| ENSG00000230615.2 |
Cytarabine |
Stomach adenocarcinoma |
0.008564012 |
Resistant |
| ENSG00000234456.3 |
Cytarabine |
Stomach adenocarcinoma |
0.031803749 |
Resistant |
| ENSG00000244252.1 |
Cytarabine |
Stomach adenocarcinoma |
0.036607863 |
Resistant |
| ENSG00000255142.1 |
Cytarabine |
Stomach adenocarcinoma |
0.03796137 |
Resistant |
| ENSG00000257829.1 |
Cytarabine |
Stomach adenocarcinoma |
0.003102699 |
Resistant |
| ENSG00000258811.1 |
Cytarabine |
Stomach adenocarcinoma |
0.039248926 |
Resistant |
| ENSG00000260630.2 |
Cytarabine |
Stomach adenocarcinoma |
0.004474844 |
Resistant |
| ENSG00000265485.1 |
Cytarabine |
Stomach adenocarcinoma |
0.003590058 |
Resistant |
| ENSG00000267198.1 |
Cytarabine |
Stomach adenocarcinoma |
0.032368107 |
Resistant |
| ENSG00000270117.1 |
Cytarabine |
Stomach adenocarcinoma |
0.046898612 |
Resistant |
| ENSG00000270210.1 |
Cytarabine |
Stomach adenocarcinoma |
0.034115974 |
Resistant |
| ENSG00000188365.3 |
Cytarabine |
Bladder urothelial carcinoma |
0.048613416 |
Sensitive |
| ENSG00000205054.2 |
Cytarabine |
Bladder urothelial carcinoma |
0.041299119 |
Sensitive |
| ENSG00000205885.3 |
Cytarabine |
Bladder urothelial carcinoma |
0.013011939 |
Sensitive |
| ENSG00000223458.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.013344416 |
Sensitive |
| ENSG00000224269.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.033390803 |
Sensitive |
| ENSG00000226645.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.04716752 |
Sensitive |
| ENSG00000226819.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.043231926 |
Sensitive |
| ENSG00000227740.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.005391013 |
Sensitive |
| ENSG00000228369.2 |
Cytarabine |
Bladder urothelial carcinoma |
0.041317506 |
Sensitive |
| ENSG00000228802.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.023432797 |
Sensitive |
| ENSG00000229719.2 |
Cytarabine |
Bladder urothelial carcinoma |
0.046552313 |
Sensitive |
| ENSG00000229983.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.041497504 |
Sensitive |
| ENSG00000232788.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.017438667 |
Sensitive |
| ENSG00000235802.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.044841018 |
Sensitive |
| ENSG00000236115.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.033130967 |
Sensitive |
| ENSG00000237126.4 |
Cytarabine |
Bladder urothelial carcinoma |
0.001860197 |
Sensitive |
| ENSG00000237181.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.038003543 |
Sensitive |
| ENSG00000238186.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.047654477 |
Sensitive |
| ENSG00000245059.2 |
Cytarabine |
Bladder urothelial carcinoma |
0.000851725 |
Sensitive |
| ENSG00000245213.2 |
Cytarabine |
Bladder urothelial carcinoma |
0.021633305 |
Sensitive |
| ENSG00000248664.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.037538841 |
Sensitive |
| ENSG00000250271.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.009970633 |
Sensitive |
| ENSG00000253399.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.033849039 |
Sensitive |
| ENSG00000255276.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.028260208 |
Sensitive |
| ENSG00000255455.2 |
Cytarabine |
Bladder urothelial carcinoma |
0.010527556 |
Sensitive |
| ENSG00000256967.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.016214798 |
Sensitive |
| ENSG00000258658.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.029987935 |
Sensitive |
| ENSG00000259327.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.030643092 |
Sensitive |
| ENSG00000259366.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.023616446 |
Sensitive |
| ENSG00000259376.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.033670718 |
Sensitive |
| ENSG00000259606.2 |
Cytarabine |
Bladder urothelial carcinoma |
0.032772458 |
Sensitive |
| ENSG00000260534.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.002685331 |
Sensitive |
| ENSG00000260583.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.009828621 |
Sensitive |
| ENSG00000260618.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.046763853 |
Sensitive |
| ENSG00000260743.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.008047829 |
Sensitive |
| ENSG00000261098.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.023728854 |
Sensitive |
| ENSG00000261589.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.002036465 |
Sensitive |
| ENSG00000262678.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.00231722 |
Sensitive |
| ENSG00000262833.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.017863628 |
Sensitive |
| ENSG00000262951.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.022083312 |
Sensitive |
| ENSG00000265185.2 |
Cytarabine |
Bladder urothelial carcinoma |
0.028590118 |
Sensitive |
| ENSG00000267565.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.006516314 |
Sensitive |
| ENSG00000269397.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.036345348 |
Sensitive |
| ENSG00000269983.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.006675367 |
Sensitive |
| ENSG00000270589.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.020474714 |
Sensitive |
| ENSG00000270704.2 |
Cytarabine |
Bladder urothelial carcinoma |
0.011511466 |
Sensitive |
| ENSG00000272463.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.011036077 |
Sensitive |
| ENSG00000272933.1 |
Cytarabine |
Bladder urothelial carcinoma |
0.018749456 |
Sensitive |
| ENSG00000187904.3 |
Cytarabine |
Breast invasive carcinoma |
0.014292636 |
Sensitive |
| ENSG00000227028.2 |
Cytarabine |
Breast invasive carcinoma |
0.001936532 |
Sensitive |
| ENSG00000235245.1 |
Cytarabine |
Breast invasive carcinoma |
0.035035218 |
Sensitive |
| ENSG00000235887.2 |
Cytarabine |
Breast invasive carcinoma |
0.044247631 |
Sensitive |
| ENSG00000237485.1 |
Cytarabine |
Breast invasive carcinoma |
0.028909654 |
Sensitive |
| ENSG00000237523.1 |
Cytarabine |
Breast invasive carcinoma |
0.031547217 |
Sensitive |
| ENSG00000248254.1 |
Cytarabine |
Breast invasive carcinoma |
0.014740444 |
Sensitive |
| ENSG00000251138.2 |
Cytarabine |
Breast invasive carcinoma |
0.036163654 |
Sensitive |
| ENSG00000251359.3 |
Cytarabine |
Breast invasive carcinoma |
0.03048413 |
Sensitive |
| ENSG00000257585.1 |
Cytarabine |
Breast invasive carcinoma |
0.028585431 |
Sensitive |
| ENSG00000260141.1 |
Cytarabine |
Breast invasive carcinoma |
0.026399354 |
Sensitive |
| ENSG00000266538.1 |
Cytarabine |
Breast invasive carcinoma |
0.030997397 |
Sensitive |
| ENSG00000267547.1 |
Cytarabine |
Breast invasive carcinoma |
0.047310166 |
Sensitive |
| ENSG00000267745.1 |
Cytarabine |
Breast invasive carcinoma |
0.01915559 |
Sensitive |
| ENSG00000182873.4 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037766308 |
Sensitive |
| ENSG00000224429.3 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041022134 |
Sensitive |
| ENSG00000225205.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017473261 |
Sensitive |
| ENSG00000227502.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022528886 |
Sensitive |
| ENSG00000228886.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04130787 |
Sensitive |
| ENSG00000229999.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005590499 |
Sensitive |
| ENSG00000231806.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037570545 |
Sensitive |
| ENSG00000233144.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.010844293 |
Sensitive |
| ENSG00000235910.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013161465 |
Sensitive |
| ENSG00000236388.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.006916585 |
Sensitive |
| ENSG00000237017.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043204335 |
Sensitive |
| ENSG00000237359.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049467044 |
Sensitive |
| ENSG00000245748.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.019628688 |
Sensitive |
| ENSG00000250312.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.044038206 |
Sensitive |
| ENSG00000260065.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01087557 |
Sensitive |
| ENSG00000261338.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013074016 |
Sensitive |
| ENSG00000264043.2 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005835017 |
Sensitive |
| ENSG00000265490.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045127227 |
Sensitive |
| ENSG00000265688.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032433611 |
Sensitive |
| ENSG00000267201.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023119747 |
Sensitive |
| ENSG00000268093.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024767913 |
Sensitive |
| ENSG00000269535.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037864626 |
Sensitive |
| ENSG00000269646.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048271585 |
Sensitive |
| ENSG00000269737.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049130574 |
Sensitive |
| ENSG00000269925.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017270402 |
Sensitive |
| ENSG00000270069.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.021592134 |
Sensitive |
| ENSG00000272361.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039602275 |
Sensitive |
| ENSG00000272368.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.047326853 |
Sensitive |
| ENSG00000273289.1 |
Cytarabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040385115 |
Sensitive |
| ENSG00000197085.7 |
Cytarabine |
Colon adenocarcinoma |
0.03720314 |
Sensitive |
| ENSG00000224049.1 |
Cytarabine |
Colon adenocarcinoma |
0.032840231 |
Sensitive |
| ENSG00000227543.3 |
Cytarabine |
Colon adenocarcinoma |
0.009987928 |
Sensitive |
| ENSG00000229105.1 |
Cytarabine |
Colon adenocarcinoma |
0.036237589 |
Sensitive |
| ENSG00000229999.2 |
Cytarabine |
Colon adenocarcinoma |
0.048901627 |
Sensitive |
| ENSG00000231595.1 |
Cytarabine |
Colon adenocarcinoma |
0.000253733 |
Sensitive |
| ENSG00000232021.2 |
Cytarabine |
Colon adenocarcinoma |
0.04641782 |
Sensitive |
| ENSG00000232445.1 |
Cytarabine |
Colon adenocarcinoma |
0.00789476 |
Sensitive |
| ENSG00000233791.1 |
Cytarabine |
Colon adenocarcinoma |
0.042195847 |
Sensitive |
| ENSG00000234614.1 |
Cytarabine |
Colon adenocarcinoma |
0.041397585 |
Sensitive |
| ENSG00000235280.2 |
Cytarabine |
Colon adenocarcinoma |
0.039132766 |
Sensitive |
| ENSG00000236305.1 |
Cytarabine |
Colon adenocarcinoma |
0.015575582 |
Sensitive |
| ENSG00000236703.1 |
Cytarabine |
Colon adenocarcinoma |
0.036179354 |
Sensitive |
| ENSG00000239911.1 |
Cytarabine |
Colon adenocarcinoma |
0.006279966 |
Sensitive |
| ENSG00000240175.1 |
Cytarabine |
Colon adenocarcinoma |
0.045795934 |
Sensitive |
| ENSG00000240758.2 |
Cytarabine |
Colon adenocarcinoma |
0.007056638 |
Sensitive |
| ENSG00000241520.1 |
Cytarabine |
Colon adenocarcinoma |
0.034783281 |
Sensitive |
| ENSG00000241985.1 |
Cytarabine |
Colon adenocarcinoma |
0.021255609 |
Sensitive |
| ENSG00000242094.1 |
Cytarabine |
Colon adenocarcinoma |
0.016431972 |
Sensitive |
| ENSG00000242154.1 |
Cytarabine |
Colon adenocarcinoma |
0.007820488 |
Sensitive |
| ENSG00000249717.1 |
Cytarabine |
Colon adenocarcinoma |
0.005509535 |
Sensitive |
| ENSG00000251307.1 |
Cytarabine |
Colon adenocarcinoma |
0.000153568 |
Sensitive |
| ENSG00000254432.1 |
Cytarabine |
Colon adenocarcinoma |
0.024150736 |
Sensitive |
| ENSG00000254485.1 |
Cytarabine |
Colon adenocarcinoma |
0.005130368 |
Sensitive |
| ENSG00000256008.1 |
Cytarabine |
Colon adenocarcinoma |
0.025088238 |
Sensitive |
| ENSG00000257613.1 |
Cytarabine |
Colon adenocarcinoma |
0.038825582 |
Sensitive |
| ENSG00000257681.1 |
Cytarabine |
Colon adenocarcinoma |
0.037020001 |
Sensitive |
| ENSG00000259125.1 |
Cytarabine |
Colon adenocarcinoma |
0.041164734 |
Sensitive |
| ENSG00000260065.1 |
Cytarabine |
Colon adenocarcinoma |
0.026128498 |
Sensitive |
| ENSG00000261804.1 |
Cytarabine |
Colon adenocarcinoma |
0.039595317 |
Sensitive |
| ENSG00000264920.1 |
Cytarabine |
Colon adenocarcinoma |
0.002473524 |
Sensitive |
| ENSG00000266283.1 |
Cytarabine |
Colon adenocarcinoma |
0.003245132 |
Sensitive |
| ENSG00000267480.1 |
Cytarabine |
Colon adenocarcinoma |
0.000128633 |
Sensitive |
| ENSG00000267868.1 |
Cytarabine |
Colon adenocarcinoma |
0.011943298 |
Sensitive |
| ENSG00000268061.1 |
Cytarabine |
Colon adenocarcinoma |
0.045542018 |
Sensitive |
| ENSG00000268605.1 |
Cytarabine |
Colon adenocarcinoma |
0.039189849 |
Sensitive |
| ENSG00000272219.1 |
Cytarabine |
Colon adenocarcinoma |
0.042983063 |
Sensitive |
| ENSG00000273257.1 |
Cytarabine |
Colon adenocarcinoma |
0.035798766 |
Sensitive |
| ENSG00000273265.1 |
Cytarabine |
Colon adenocarcinoma |
0.021194485 |
Sensitive |
| ENSG00000273295.1 |
Cytarabine |
Colon adenocarcinoma |
0.004100675 |
Sensitive |
| ENSG00000273476.1 |
Cytarabine |
Colon adenocarcinoma |
0.03580428 |
Sensitive |
| ENSG00000224141.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039207626 |
Sensitive |
| ENSG00000228649.4 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000621471 |
Sensitive |
| ENSG00000229531.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008482588 |
Sensitive |
| ENSG00000242125.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01684206 |
Sensitive |
| ENSG00000253720.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016801201 |
Sensitive |
| ENSG00000258344.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012528779 |
Sensitive |
| ENSG00000258525.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031795242 |
Sensitive |
| ENSG00000261560.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018484991 |
Sensitive |
| ENSG00000266936.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048161767 |
Sensitive |
| ENSG00000267151.2 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005770863 |
Sensitive |
| ENSG00000267476.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043935219 |
Sensitive |
| ENSG00000267567.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0333085 |
Sensitive |
| ENSG00000271032.1 |
Cytarabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004888616 |
Sensitive |
| ENSG00000223401.1 |
Cytarabine |
Esophageal cancer |
0.005153089 |
Sensitive |
| ENSG00000224842.2 |
Cytarabine |
Esophageal cancer |
0.007638488 |
Sensitive |
| ENSG00000224945.1 |
Cytarabine |
Esophageal cancer |
0.048136688 |
Sensitive |
| ENSG00000228369.2 |
Cytarabine |
Esophageal cancer |
0.030832393 |
Sensitive |
| ENSG00000229891.1 |
Cytarabine |
Esophageal cancer |
0.042523664 |
Sensitive |
| ENSG00000231310.2 |
Cytarabine |
Esophageal cancer |
0.020416497 |
Sensitive |
| ENSG00000231703.2 |
Cytarabine |
Esophageal cancer |
0.046512969 |
Sensitive |
| ENSG00000232021.2 |
Cytarabine |
Esophageal cancer |
0.034728482 |
Sensitive |
| ENSG00000233033.1 |
Cytarabine |
Esophageal cancer |
0.020279758 |
Sensitive |
| ENSG00000234185.2 |
Cytarabine |
Esophageal cancer |
0.024104511 |
Sensitive |
| ENSG00000234352.5 |
Cytarabine |
Esophageal cancer |
0.01248228 |
Sensitive |
| ENSG00000235138.1 |
Cytarabine |
Esophageal cancer |
0.011258401 |
Sensitive |
| ENSG00000240661.1 |
Cytarabine |
Esophageal cancer |
0.041896325 |
Sensitive |
| ENSG00000244558.1 |
Cytarabine |
Esophageal cancer |
0.041207822 |
Sensitive |
| ENSG00000245498.2 |
Cytarabine |
Esophageal cancer |
0.045993129 |
Sensitive |
| ENSG00000246982.2 |
Cytarabine |
Esophageal cancer |
0.049443029 |
Sensitive |
| ENSG00000247925.2 |
Cytarabine |
Esophageal cancer |
0.03201788 |
Sensitive |
| ENSG00000250101.1 |
Cytarabine |
Esophageal cancer |
0.048501396 |
Sensitive |
| ENSG00000251661.3 |
Cytarabine |
Esophageal cancer |
0.035314441 |
Sensitive |
| ENSG00000253704.1 |
Cytarabine |
Esophageal cancer |
0.033912579 |
Sensitive |
| ENSG00000255089.1 |
Cytarabine |
Esophageal cancer |
0.00061424 |
Sensitive |
| ENSG00000257696.1 |
Cytarabine |
Esophageal cancer |
0.020227995 |
Sensitive |
| ENSG00000258122.1 |
Cytarabine |
Esophageal cancer |
0.028301282 |
Sensitive |
| ENSG00000258553.1 |
Cytarabine |
Esophageal cancer |
0.003880743 |
Sensitive |
| ENSG00000259448.2 |
Cytarabine |
Esophageal cancer |
0.006450004 |
Sensitive |
| ENSG00000259867.1 |
Cytarabine |
Esophageal cancer |
0.043688126 |
Sensitive |
| ENSG00000259891.1 |
Cytarabine |
Esophageal cancer |
0.045983816 |
Sensitive |
| ENSG00000260100.1 |
Cytarabine |
Esophageal cancer |
0.006246455 |
Sensitive |
| ENSG00000260288.2 |
Cytarabine |
Esophageal cancer |
0.031899926 |
Sensitive |
| ENSG00000260316.1 |
Cytarabine |
Esophageal cancer |
0.015074971 |
Sensitive |
| ENSG00000260351.1 |
Cytarabine |
Esophageal cancer |
0.046464468 |
Sensitive |
| ENSG00000260807.2 |
Cytarabine |
Esophageal cancer |
0.046683394 |
Sensitive |
| ENSG00000261117.1 |
Cytarabine |
Esophageal cancer |
0.036415616 |
Sensitive |
| ENSG00000261329.1 |
Cytarabine |
Esophageal cancer |
0.014335421 |
Sensitive |
| ENSG00000261334.1 |
Cytarabine |
Esophageal cancer |
0.030401567 |
Sensitive |
| ENSG00000261610.1 |
Cytarabine |
Esophageal cancer |
0.00501277 |
Sensitive |
| ENSG00000262312.1 |
Cytarabine |
Esophageal cancer |
0.040583235 |
Sensitive |
| ENSG00000267104.1 |
Cytarabine |
Esophageal cancer |
0.049622921 |
Sensitive |
| ENSG00000268230.1 |
Cytarabine |
Esophageal cancer |
0.033174486 |
Sensitive |
| ENSG00000268650.3 |
Cytarabine |
Esophageal cancer |
0.038127246 |
Sensitive |
| ENSG00000268895.1 |
Cytarabine |
Esophageal cancer |
0.019692464 |
Sensitive |
| ENSG00000271032.1 |
Cytarabine |
Esophageal cancer |
0.007324425 |
Sensitive |
| ENSG00000271789.1 |
Cytarabine |
Esophageal cancer |
0.045721561 |
Sensitive |
| ENSG00000271815.1 |
Cytarabine |
Esophageal cancer |
0.013444526 |
Sensitive |
| ENSG00000272076.1 |
Cytarabine |
Esophageal cancer |
0.005195104 |
Sensitive |
| ENSG00000272699.1 |
Cytarabine |
Esophageal cancer |
0.033476312 |
Sensitive |
| ENSG00000273473.1 |
Cytarabine |
Esophageal cancer |
0.008707882 |
Sensitive |
| ENSG00000223714.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.037181564 |
Sensitive |
| ENSG00000226381.3 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.006857756 |
Sensitive |
| ENSG00000230542.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.048892206 |
Sensitive |
| ENSG00000233246.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.033534 |
Sensitive |
| ENSG00000234084.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.037470478 |
Sensitive |
| ENSG00000236153.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.032458503 |
Sensitive |
| ENSG00000236537.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.006017171 |
Sensitive |
| ENSG00000244327.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.036468249 |
Sensitive |
| ENSG00000254353.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.033868128 |
Sensitive |
| ENSG00000254486.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.036456769 |
Sensitive |
| ENSG00000258976.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.046958073 |
Sensitive |
| ENSG00000259462.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.035202152 |
Sensitive |
| ENSG00000266900.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.040312088 |
Sensitive |
| ENSG00000267778.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.032685254 |
Sensitive |
| ENSG00000268605.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.039098093 |
Sensitive |
| ENSG00000269066.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.005353521 |
Sensitive |
| ENSG00000269983.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.009511521 |
Sensitive |
| ENSG00000271840.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.028679852 |
Sensitive |
| ENSG00000271964.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.020020544 |
Sensitive |
| ENSG00000272087.1 |
Cytarabine |
Kidney renal clear cell carcinoma |
0.023462285 |
Sensitive |
| ENSG00000204758.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.028745598 |
Sensitive |
| ENSG00000213468.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.049596173 |
Sensitive |
| ENSG00000222044.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.041148172 |
Sensitive |
| ENSG00000223571.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.008974197 |
Sensitive |
| ENSG00000224790.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.037547892 |
Sensitive |
| ENSG00000225978.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.045850885 |
Sensitive |
| ENSG00000226578.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.004767224 |
Sensitive |
| ENSG00000227492.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.044955567 |
Sensitive |
| ENSG00000229191.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.03528342 |
Sensitive |
| ENSG00000229776.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.009067284 |
Sensitive |
| ENSG00000230552.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.043749499 |
Sensitive |
| ENSG00000231439.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.00995417 |
Sensitive |
| ENSG00000231851.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.02077861 |
Sensitive |
| ENSG00000233593.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.047964539 |
Sensitive |
| ENSG00000233627.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.045364159 |
Sensitive |
| ENSG00000234509.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.009897676 |
Sensitive |
| ENSG00000235172.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.021439003 |
Sensitive |
| ENSG00000235802.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.018970377 |
Sensitive |
| ENSG00000236066.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.03786584 |
Sensitive |
| ENSG00000236537.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.016885463 |
Sensitive |
| ENSG00000237883.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.038170033 |
Sensitive |
| ENSG00000242759.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.043820033 |
Sensitive |
| ENSG00000244124.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.023630387 |
Sensitive |
| ENSG00000244879.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.009927298 |
Sensitive |
| ENSG00000245526.4 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.044032755 |
Sensitive |
| ENSG00000246174.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.031457343 |
Sensitive |
| ENSG00000247708.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.019923162 |
Sensitive |
| ENSG00000247970.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.03319273 |
Sensitive |
| ENSG00000250027.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.038585997 |
Sensitive |
| ENSG00000254258.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.035307583 |
Sensitive |
| ENSG00000254295.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.027281453 |
Sensitive |
| ENSG00000254495.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.047404269 |
Sensitive |
| ENSG00000255084.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.008350499 |
Sensitive |
| ENSG00000255449.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.002154545 |
Sensitive |
| ENSG00000257698.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.04516593 |
Sensitive |
| ENSG00000258526.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.031020686 |
Sensitive |
| ENSG00000259310.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.02831915 |
Sensitive |
| ENSG00000259618.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.016762595 |
Sensitive |
| ENSG00000259715.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.012023304 |
Sensitive |
| ENSG00000259915.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.02860546 |
Sensitive |
| ENSG00000259935.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.040053679 |
Sensitive |
| ENSG00000260466.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.034894232 |
Sensitive |
| ENSG00000260626.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.03180943 |
Sensitive |
| ENSG00000260751.2 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.018330785 |
Sensitive |
| ENSG00000260927.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.03409958 |
Sensitive |
| ENSG00000261186.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.014616215 |
Sensitive |
| ENSG00000261188.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.044842275 |
Sensitive |
| ENSG00000262074.3 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.043896585 |
Sensitive |
| ENSG00000263727.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.007677039 |
Sensitive |
| ENSG00000265474.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.005542017 |
Sensitive |
| ENSG00000265800.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.009589747 |
Sensitive |
| ENSG00000266654.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.027404414 |
Sensitive |
| ENSG00000266709.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.019429924 |
Sensitive |
| ENSG00000266922.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.041062098 |
Sensitive |
| ENSG00000268201.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.047368342 |
Sensitive |
| ENSG00000268262.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.048554471 |
Sensitive |
| ENSG00000270159.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.030831634 |
Sensitive |
| ENSG00000270681.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.026396556 |
Sensitive |
| ENSG00000271856.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.027569245 |
Sensitive |
| ENSG00000272416.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.039748104 |
Sensitive |
| ENSG00000272417.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.020992396 |
Sensitive |
| ENSG00000272446.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.020041696 |
Sensitive |
| ENSG00000272520.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.022694083 |
Sensitive |
| ENSG00000272659.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.045133459 |
Sensitive |
| ENSG00000272795.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.034263317 |
Sensitive |
| ENSG00000273015.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.016656047 |
Sensitive |
| ENSG00000273185.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.035647383 |
Sensitive |
| ENSG00000273355.1 |
Cytarabine |
Chronic Lymphocytic Leukemia |
0.004587034 |
Sensitive |
| ENSG00000183242.7 |
Cytarabine |
Brain lower grade glioma |
0.025460974 |
Sensitive |
| ENSG00000189229.10 |
Cytarabine |
Brain lower grade glioma |
0.029836451 |
Sensitive |
| ENSG00000216863.5 |
Cytarabine |
Brain lower grade glioma |
0.030475491 |
Sensitive |
| ENSG00000224063.1 |
Cytarabine |
Brain lower grade glioma |
0.015380657 |
Sensitive |
| ENSG00000224271.1 |
Cytarabine |
Brain lower grade glioma |
0.047879388 |
Sensitive |
| ENSG00000224490.1 |
Cytarabine |
Brain lower grade glioma |
0.015120932 |
Sensitive |
| ENSG00000225684.3 |
Cytarabine |
Brain lower grade glioma |
0.033570826 |
Sensitive |
| ENSG00000227695.1 |
Cytarabine |
Brain lower grade glioma |
0.038143482 |
Sensitive |
| ENSG00000228192.3 |
Cytarabine |
Brain lower grade glioma |
0.039094815 |
Sensitive |
| ENSG00000229666.1 |
Cytarabine |
Brain lower grade glioma |
0.049650572 |
Sensitive |
| ENSG00000230061.1 |
Cytarabine |
Brain lower grade glioma |
0.029592707 |
Sensitive |
| ENSG00000230184.1 |
Cytarabine |
Brain lower grade glioma |
0.047830181 |
Sensitive |
| ENSG00000230410.1 |
Cytarabine |
Brain lower grade glioma |
0.034027652 |
Sensitive |
| ENSG00000231050.1 |
Cytarabine |
Brain lower grade glioma |
0.026049319 |
Sensitive |
| ENSG00000231528.2 |
Cytarabine |
Brain lower grade glioma |
0.031800838 |
Sensitive |
| ENSG00000231966.1 |
Cytarabine |
Brain lower grade glioma |
0.03492189 |
Sensitive |
| ENSG00000232184.1 |
Cytarabine |
Brain lower grade glioma |
0.049428736 |
Sensitive |
| ENSG00000232328.1 |
Cytarabine |
Brain lower grade glioma |
0.048035157 |
Sensitive |
| ENSG00000232386.5 |
Cytarabine |
Brain lower grade glioma |
0.045285994 |
Sensitive |
| ENSG00000232504.4 |
Cytarabine |
Brain lower grade glioma |
0.0398611 |
Sensitive |
| ENSG00000232827.2 |
Cytarabine |
Brain lower grade glioma |
0.049128868 |
Sensitive |
| ENSG00000234183.1 |
Cytarabine |
Brain lower grade glioma |
0.034909333 |
Sensitive |
| ENSG00000234193.1 |
Cytarabine |
Brain lower grade glioma |
0.042944917 |
Sensitive |
| ENSG00000234503.1 |
Cytarabine |
Brain lower grade glioma |
0.043245522 |
Sensitive |
| ENSG00000234753.1 |
Cytarabine |
Brain lower grade glioma |
0.00796239 |
Sensitive |
| ENSG00000237520.1 |
Cytarabine |
Brain lower grade glioma |
0.04696856 |
Sensitive |
| ENSG00000237548.1 |
Cytarabine |
Brain lower grade glioma |
0.023560185 |
Sensitive |
| ENSG00000237609.1 |
Cytarabine |
Brain lower grade glioma |
0.041533225 |
Sensitive |
| ENSG00000238133.2 |
Cytarabine |
Brain lower grade glioma |
0.046223007 |
Sensitive |
| ENSG00000240063.1 |
Cytarabine |
Brain lower grade glioma |
0.042615299 |
Sensitive |
| ENSG00000243368.2 |
Cytarabine |
Brain lower grade glioma |
0.039855221 |
Sensitive |
| ENSG00000243629.1 |
Cytarabine |
Brain lower grade glioma |
0.042624131 |
Sensitive |
| ENSG00000247675.2 |
Cytarabine |
Brain lower grade glioma |
0.03743036 |
Sensitive |
| ENSG00000248538.2 |
Cytarabine |
Brain lower grade glioma |
0.012104866 |
Sensitive |
| ENSG00000248968.1 |
Cytarabine |
Brain lower grade glioma |
0.011976997 |
Sensitive |
| ENSG00000249740.1 |
Cytarabine |
Brain lower grade glioma |
0.036301843 |
Sensitive |
| ENSG00000250222.1 |
Cytarabine |
Brain lower grade glioma |
0.003086455 |
Sensitive |
| ENSG00000250362.1 |
Cytarabine |
Brain lower grade glioma |
0.042861759 |
Sensitive |
| ENSG00000251144.1 |
Cytarabine |
Brain lower grade glioma |
0.03460944 |
Sensitive |
| ENSG00000251148.1 |
Cytarabine |
Brain lower grade glioma |
0.027452778 |
Sensitive |
| ENSG00000251257.1 |
Cytarabine |
Brain lower grade glioma |
0.040211074 |
Sensitive |
| ENSG00000251350.1 |
Cytarabine |
Brain lower grade glioma |
0.041031119 |
Sensitive |
| ENSG00000251450.1 |
Cytarabine |
Brain lower grade glioma |
0.044427177 |
Sensitive |
| ENSG00000251611.1 |
Cytarabine |
Brain lower grade glioma |
0.037677992 |
Sensitive |
| ENSG00000253414.2 |
Cytarabine |
Brain lower grade glioma |
0.046028862 |
Sensitive |
| ENSG00000253567.1 |
Cytarabine |
Brain lower grade glioma |
0.033618229 |
Sensitive |
| ENSG00000254606.1 |
Cytarabine |
Brain lower grade glioma |
0.04798879 |
Sensitive |
| ENSG00000254699.1 |
Cytarabine |
Brain lower grade glioma |
0.043503286 |
Sensitive |
| ENSG00000255237.1 |
Cytarabine |
Brain lower grade glioma |
0.037700814 |
Sensitive |
| ENSG00000255992.1 |
Cytarabine |
Brain lower grade glioma |
0.008885866 |
Sensitive |
| ENSG00000256943.1 |
Cytarabine |
Brain lower grade glioma |
0.045956554 |
Sensitive |
| ENSG00000257256.1 |
Cytarabine |
Brain lower grade glioma |
0.044419931 |
Sensitive |
| ENSG00000257261.1 |
Cytarabine |
Brain lower grade glioma |
0.010857679 |
Sensitive |
| ENSG00000257449.1 |
Cytarabine |
Brain lower grade glioma |
0.02229108 |
Sensitive |
| ENSG00000258457.1 |
Cytarabine |
Brain lower grade glioma |
0.042849205 |
Sensitive |
| ENSG00000258998.1 |
Cytarabine |
Brain lower grade glioma |
0.037547163 |
Sensitive |
| ENSG00000260253.1 |
Cytarabine |
Brain lower grade glioma |
0.048098294 |
Sensitive |
| ENSG00000260288.2 |
Cytarabine |
Brain lower grade glioma |
0.015087864 |
Sensitive |
| ENSG00000260352.1 |
Cytarabine |
Brain lower grade glioma |
0.02393366 |
Sensitive |
| ENSG00000260757.1 |
Cytarabine |
Brain lower grade glioma |
0.039397501 |
Sensitive |
| ENSG00000261211.1 |
Cytarabine |
Brain lower grade glioma |
0.025831316 |
Sensitive |
| ENSG00000261392.1 |
Cytarabine |
Brain lower grade glioma |
0.030429822 |
Sensitive |
| ENSG00000262136.1 |
Cytarabine |
Brain lower grade glioma |
0.008417552 |
Sensitive |
| ENSG00000262823.1 |
Cytarabine |
Brain lower grade glioma |
0.037693261 |
Sensitive |
| ENSG00000262905.1 |
Cytarabine |
Brain lower grade glioma |
0.024381685 |
Sensitive |
| ENSG00000263105.1 |
Cytarabine |
Brain lower grade glioma |
0.045343415 |
Sensitive |
| ENSG00000263293.1 |
Cytarabine |
Brain lower grade glioma |
0.047179475 |
Sensitive |
| ENSG00000263718.2 |
Cytarabine |
Brain lower grade glioma |
0.02701799 |
Sensitive |
| ENSG00000266079.2 |
Cytarabine |
Brain lower grade glioma |
0.030222573 |
Sensitive |
| ENSG00000266126.1 |
Cytarabine |
Brain lower grade glioma |
0.02813538 |
Sensitive |
| ENSG00000266261.1 |
Cytarabine |
Brain lower grade glioma |
0.022587417 |
Sensitive |
| ENSG00000267159.1 |
Cytarabine |
Brain lower grade glioma |
0.001718452 |
Sensitive |
| ENSG00000267174.1 |
Cytarabine |
Brain lower grade glioma |
0.028483175 |
Sensitive |
| ENSG00000267667.1 |
Cytarabine |
Brain lower grade glioma |
0.039868426 |
Sensitive |
| ENSG00000268605.1 |
Cytarabine |
Brain lower grade glioma |
0.047061744 |
Sensitive |
| ENSG00000272273.1 |
Cytarabine |
Brain lower grade glioma |
0.036787831 |
Sensitive |
| ENSG00000272564.1 |
Cytarabine |
Brain lower grade glioma |
0.004676773 |
Sensitive |
| ENSG00000273406.1 |
Cytarabine |
Brain lower grade glioma |
0.00291733 |
Sensitive |
| ENSG00000100181.17 |
Cytarabine |
Lung squamous cell carcinoma |
0.044563615 |
Sensitive |
| ENSG00000183242.7 |
Cytarabine |
Lung squamous cell carcinoma |
0.032983281 |
Sensitive |
| ENSG00000223528.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.044180452 |
Sensitive |
| ENSG00000224635.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.005653129 |
Sensitive |
| ENSG00000225434.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.026534683 |
Sensitive |
| ENSG00000225745.4 |
Cytarabine |
Lung squamous cell carcinoma |
0.023293646 |
Sensitive |
| ENSG00000226375.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.036259608 |
Sensitive |
| ENSG00000226440.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.049811551 |
Sensitive |
| ENSG00000226496.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.048676757 |
Sensitive |
| ENSG00000227925.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.049254367 |
Sensitive |
| ENSG00000229401.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.020181273 |
Sensitive |
| ENSG00000230001.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.032769124 |
Sensitive |
| ENSG00000231290.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.039865604 |
Sensitive |
| ENSG00000231367.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.015196302 |
Sensitive |
| ENSG00000232194.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.030683727 |
Sensitive |
| ENSG00000232290.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.027150347 |
Sensitive |
| ENSG00000232445.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.015452798 |
Sensitive |
| ENSG00000233237.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.011152414 |
Sensitive |
| ENSG00000234361.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.030584169 |
Sensitive |
| ENSG00000234614.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.030294201 |
Sensitive |
| ENSG00000234902.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.029280882 |
Sensitive |
| ENSG00000235593.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.040263746 |
Sensitive |
| ENSG00000236098.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.026131502 |
Sensitive |
| ENSG00000236234.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.041780892 |
Sensitive |
| ENSG00000236366.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025357705 |
Sensitive |
| ENSG00000237813.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.047618818 |
Sensitive |
| ENSG00000237993.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.027974201 |
Sensitive |
| ENSG00000238042.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.033448359 |
Sensitive |
| ENSG00000238184.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034680139 |
Sensitive |
| ENSG00000238268.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.036799688 |
Sensitive |
| ENSG00000240006.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025537803 |
Sensitive |
| ENSG00000240440.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.007364216 |
Sensitive |
| ENSG00000241042.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.027750722 |
Sensitive |
| ENSG00000242147.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.047922606 |
Sensitive |
| ENSG00000243415.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.020648575 |
Sensitive |
| ENSG00000245248.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.011700255 |
Sensitive |
| ENSG00000246640.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.02614385 |
Sensitive |
| ENSG00000247311.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.036406066 |
Sensitive |
| ENSG00000248468.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.000587336 |
Sensitive |
| ENSG00000248647.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.030279579 |
Sensitive |
| ENSG00000249102.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.021998855 |
Sensitive |
| ENSG00000249867.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.019917272 |
Sensitive |
| ENSG00000250072.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.035326622 |
Sensitive |
| ENSG00000250608.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.0280365 |
Sensitive |
| ENSG00000250829.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.030796411 |
Sensitive |
| ENSG00000250899.3 |
Cytarabine |
Lung squamous cell carcinoma |
0.033786822 |
Sensitive |
| ENSG00000250961.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.031002067 |
Sensitive |
| ENSG00000251031.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.027326885 |
Sensitive |
| ENSG00000251179.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.016496077 |
Sensitive |
| ENSG00000251281.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.037152886 |
Sensitive |
| ENSG00000251577.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.037727031 |
Sensitive |
| ENSG00000253530.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.029538496 |
Sensitive |
| ENSG00000253892.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.046610261 |
Sensitive |
| ENSG00000254526.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.00983338 |
Sensitive |
| ENSG00000255090.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.048822118 |
Sensitive |
| ENSG00000255094.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.009007844 |
Sensitive |
| ENSG00000255227.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.04565708 |
Sensitive |
| ENSG00000257027.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.027137649 |
Sensitive |
| ENSG00000257886.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.033694699 |
Sensitive |
| ENSG00000257925.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.019218005 |
Sensitive |
| ENSG00000259005.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.018494157 |
Sensitive |
| ENSG00000259265.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.030274576 |
Sensitive |
| ENSG00000259283.2 |
Cytarabine |
Lung squamous cell carcinoma |
0.02105124 |
Sensitive |
| ENSG00000260877.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.049045538 |
Sensitive |
| ENSG00000261000.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.025171445 |
Sensitive |
| ENSG00000261295.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.026799744 |
Sensitive |
| ENSG00000261438.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.041531566 |
Sensitive |
| ENSG00000261662.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.005716611 |
Sensitive |
| ENSG00000262339.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.00617336 |
Sensitive |
| ENSG00000262370.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.04646614 |
Sensitive |
| ENSG00000267316.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.018444603 |
Sensitive |
| ENSG00000267405.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.034998899 |
Sensitive |
| ENSG00000267764.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.005736239 |
Sensitive |
| ENSG00000269927.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.014735758 |
Sensitive |
| ENSG00000269946.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.038063821 |
Sensitive |
| ENSG00000269966.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.011812381 |
Sensitive |
| ENSG00000271761.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.035910172 |
Sensitive |
| ENSG00000272324.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.03169409 |
Sensitive |
| ENSG00000272431.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.027637732 |
Sensitive |
| ENSG00000272620.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.02911976 |
Sensitive |
| ENSG00000273307.1 |
Cytarabine |
Lung squamous cell carcinoma |
0.042502991 |
Sensitive |
| ENSG00000182648.7 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016247031 |
Sensitive |
| ENSG00000226419.2 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02157891 |
Sensitive |
| ENSG00000228962.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046466738 |
Sensitive |
| ENSG00000231249.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016422931 |
Sensitive |
| ENSG00000233937.2 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030486669 |
Sensitive |
| ENSG00000234232.2 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038435981 |
Sensitive |
| ENSG00000234327.3 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015001654 |
Sensitive |
| ENSG00000235245.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006487068 |
Sensitive |
| ENSG00000235795.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016741678 |
Sensitive |
| ENSG00000235903.3 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021643694 |
Sensitive |
| ENSG00000239213.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012281811 |
Sensitive |
| ENSG00000240137.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035619539 |
Sensitive |
| ENSG00000248161.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009563695 |
Sensitive |
| ENSG00000249867.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022192216 |
Sensitive |
| ENSG00000253741.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037556235 |
Sensitive |
| ENSG00000254028.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022463133 |
Sensitive |
| ENSG00000259628.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015561462 |
Sensitive |
| ENSG00000260589.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047732507 |
Sensitive |
| ENSG00000260597.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019325206 |
Sensitive |
| ENSG00000260655.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000869992 |
Sensitive |
| ENSG00000260877.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024097177 |
Sensitive |
| ENSG00000261188.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035371412 |
Sensitive |
| ENSG00000269980.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038200458 |
Sensitive |
| ENSG00000271849.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03453515 |
Sensitive |
| ENSG00000271912.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044034672 |
Sensitive |
| ENSG00000271963.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00170636 |
Sensitive |
| ENSG00000272983.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031685227 |
Sensitive |
| ENSG00000273132.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045878024 |
Sensitive |
| ENSG00000273297.1 |
Cytarabine |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000573094 |
Sensitive |
| ENSG00000157306.10 |
Cytarabine |
Pancreatic adenocarcinoma |
0.001793811 |
Sensitive |
| ENSG00000172250.10 |
Cytarabine |
Pancreatic adenocarcinoma |
0.048937357 |
Sensitive |
| ENSG00000175873.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.029637732 |
Sensitive |
| ENSG00000179219.5 |
Cytarabine |
Pancreatic adenocarcinoma |
0.010988654 |
Sensitive |
| ENSG00000196559.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.003148438 |
Sensitive |
| ENSG00000198468.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.028266175 |
Sensitive |
| ENSG00000203279.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.018926819 |
Sensitive |
| ENSG00000203307.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.01299171 |
Sensitive |
| ENSG00000203999.4 |
Cytarabine |
Pancreatic adenocarcinoma |
0.022427991 |
Sensitive |
| ENSG00000204934.6 |
Cytarabine |
Pancreatic adenocarcinoma |
0.044811284 |
Sensitive |
| ENSG00000206417.4 |
Cytarabine |
Pancreatic adenocarcinoma |
0.001543208 |
Sensitive |
| ENSG00000213971.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.021393897 |
Sensitive |
| ENSG00000214770.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.010753031 |
Sensitive |
| ENSG00000218510.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.047981573 |
Sensitive |
| ENSG00000223635.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.029183628 |
Sensitive |
| ENSG00000223711.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.023364605 |
Sensitive |
| ENSG00000223714.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.043729139 |
Sensitive |
| ENSG00000223891.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.029918585 |
Sensitive |
| ENSG00000224050.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.027076298 |
Sensitive |
| ENSG00000224165.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.049537187 |
Sensitive |
| ENSG00000224614.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.027115738 |
Sensitive |
| ENSG00000224699.4 |
Cytarabine |
Pancreatic adenocarcinoma |
0.006445676 |
Sensitive |
| ENSG00000224863.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.011719512 |
Sensitive |
| ENSG00000224969.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.038295508 |
Sensitive |
| ENSG00000225506.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.02658917 |
Sensitive |
| ENSG00000225518.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.034839294 |
Sensitive |
| ENSG00000225761.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.026873656 |
Sensitive |
| ENSG00000225914.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.013929906 |
Sensitive |
| ENSG00000225975.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.04829731 |
Sensitive |
| ENSG00000226445.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.007295371 |
Sensitive |
| ENSG00000226920.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.028418909 |
Sensitive |
| ENSG00000227603.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.036136768 |
Sensitive |
| ENSG00000227946.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.027977139 |
Sensitive |
| ENSG00000228126.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.017446293 |
Sensitive |
| ENSG00000228649.4 |
Cytarabine |
Pancreatic adenocarcinoma |
0.01370908 |
Sensitive |
| ENSG00000228989.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.028459555 |
Sensitive |
| ENSG00000229591.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.00358295 |
Sensitive |
| ENSG00000229839.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.038233106 |
Sensitive |
| ENSG00000229905.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.00177333 |
Sensitive |
| ENSG00000230415.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.027835624 |
Sensitive |
| ENSG00000230896.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.0000472 |
Sensitive |
| ENSG00000231010.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.016594785 |
Sensitive |
| ENSG00000231050.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.000787354 |
Sensitive |
| ENSG00000231305.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.023046834 |
Sensitive |
| ENSG00000231742.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.020212382 |
Sensitive |
| ENSG00000231770.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.042283302 |
Sensitive |
| ENSG00000231856.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.028928534 |
Sensitive |
| ENSG00000231999.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.035666264 |
Sensitive |
| ENSG00000232028.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.00782784 |
Sensitive |
| ENSG00000232233.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.007384523 |
Sensitive |
| ENSG00000232485.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.026426353 |
Sensitive |
| ENSG00000232611.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.0257135 |
Sensitive |
| ENSG00000232956.4 |
Cytarabine |
Pancreatic adenocarcinoma |
0.001040644 |
Sensitive |
| ENSG00000233016.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.023466986 |
Sensitive |
| ENSG00000233069.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.044847087 |
Sensitive |
| ENSG00000233077.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.013255122 |
Sensitive |
| ENSG00000233250.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.008184698 |
Sensitive |
| ENSG00000233411.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.02181827 |
Sensitive |
| ENSG00000233593.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.016633131 |
Sensitive |
| ENSG00000233611.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.042043923 |
Sensitive |
| ENSG00000233806.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.014445449 |
Sensitive |
| ENSG00000233937.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.022947475 |
Sensitive |
| ENSG00000234084.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.009679118 |
Sensitive |
| ENSG00000234171.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.044484975 |
Sensitive |
| ENSG00000234235.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.002094749 |
Sensitive |
| ENSG00000234722.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.00782461 |
Sensitive |
| ENSG00000234741.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.01015232 |
Sensitive |
| ENSG00000234753.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.008396795 |
Sensitive |
| ENSG00000234917.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.024581535 |
Sensitive |
| ENSG00000235100.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.028760844 |
Sensitive |
| ENSG00000235106.4 |
Cytarabine |
Pancreatic adenocarcinoma |
0.001010161 |
Sensitive |
| ENSG00000235117.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.041879154 |
Sensitive |
| ENSG00000235477.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.046325024 |
Sensitive |
| ENSG00000235954.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.017058392 |
Sensitive |
| ENSG00000236031.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.030616198 |
Sensitive |
| ENSG00000236066.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.0000388 |
Sensitive |
| ENSG00000236200.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.016599032 |
Sensitive |
| ENSG00000236423.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.023082358 |
Sensitive |
| ENSG00000236472.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.032460823 |
Sensitive |
| ENSG00000236558.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.009531951 |
Sensitive |
| ENSG00000236859.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.015815756 |
Sensitive |
| ENSG00000237310.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.005813209 |
Sensitive |
| ENSG00000237424.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.017082443 |
Sensitive |
| ENSG00000237738.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.046933631 |
Sensitive |
| ENSG00000237756.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.007587979 |
Sensitive |
| ENSG00000237805.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.034811549 |
Sensitive |
| ENSG00000237886.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.009951794 |
Sensitive |
| ENSG00000237903.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.013739228 |
Sensitive |
| ENSG00000238107.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.020760114 |
Sensitive |
| ENSG00000238186.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.022219587 |
Sensitive |
| ENSG00000238198.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.026114199 |
Sensitive |
| ENSG00000240063.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.022848262 |
Sensitive |
| ENSG00000240449.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.010709516 |
Sensitive |
| ENSG00000240915.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.048253833 |
Sensitive |
| ENSG00000241520.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.009832894 |
Sensitive |
| ENSG00000241570.4 |
Cytarabine |
Pancreatic adenocarcinoma |
0.008312173 |
Sensitive |
| ENSG00000242282.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.026839782 |
Sensitive |
| ENSG00000243055.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.01643449 |
Sensitive |
| ENSG00000243819.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.025669182 |
Sensitive |
| ENSG00000243960.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.007178876 |
Sensitive |
| ENSG00000244252.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.030649929 |
Sensitive |
| ENSG00000244513.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.023607449 |
Sensitive |
| ENSG00000244879.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.024232959 |
Sensitive |
| ENSG00000245059.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.00166816 |
Sensitive |
| ENSG00000246465.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.036093788 |
Sensitive |
| ENSG00000246731.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.025351082 |
Sensitive |
| ENSG00000247595.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.00290884 |
Sensitive |
| ENSG00000247796.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.031864229 |
Sensitive |
| ENSG00000248367.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.036994084 |
Sensitive |
| ENSG00000248559.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.038515151 |
Sensitive |
| ENSG00000249356.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.0000476 |
Sensitive |
| ENSG00000249359.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.03027933 |
Sensitive |
| ENSG00000249684.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.046483277 |
Sensitive |
| ENSG00000249859.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.027563236 |
Sensitive |
| ENSG00000250132.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.03443466 |
Sensitive |
| ENSG00000250286.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.001733212 |
Sensitive |
| ENSG00000250820.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.00116256 |
Sensitive |
| ENSG00000251221.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.040002321 |
Sensitive |
| ENSG00000253315.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.005718129 |
Sensitive |
| ENSG00000253559.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.047832731 |
Sensitive |
| ENSG00000253695.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.035913142 |
Sensitive |
| ENSG00000253961.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.017450998 |
Sensitive |
| ENSG00000254473.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.041412527 |
Sensitive |
| ENSG00000256006.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.007102178 |
Sensitive |
| ENSG00000256312.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.000224114 |
Sensitive |
| ENSG00000256576.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.042470639 |
Sensitive |
| ENSG00000259623.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.02038695 |
Sensitive |
| ENSG00000259678.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.047194352 |
Sensitive |
| ENSG00000259714.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.04809274 |
Sensitive |
| ENSG00000259802.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.001166405 |
Sensitive |
| ENSG00000259886.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.016343528 |
Sensitive |
| ENSG00000259891.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.024535301 |
Sensitive |
| ENSG00000259915.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.038381555 |
Sensitive |
| ENSG00000259943.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.017921287 |
Sensitive |
| ENSG00000260005.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.027909042 |
Sensitive |
| ENSG00000260046.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.045865908 |
Sensitive |
| ENSG00000260051.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.042894061 |
Sensitive |
| ENSG00000260060.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.045085482 |
Sensitive |
| ENSG00000260086.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.003043533 |
Sensitive |
| ENSG00000260236.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.027279795 |
Sensitive |
| ENSG00000260329.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.020143522 |
Sensitive |
| ENSG00000260369.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.040588566 |
Sensitive |
| ENSG00000260388.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.002501494 |
Sensitive |
| ENSG00000260394.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.015123646 |
Sensitive |
| ENSG00000260488.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.028854244 |
Sensitive |
| ENSG00000260515.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.014484372 |
Sensitive |
| ENSG00000260541.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.011924915 |
Sensitive |
| ENSG00000260708.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.005545466 |
Sensitive |
| ENSG00000260743.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.012434665 |
Sensitive |
| ENSG00000260757.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.012077899 |
Sensitive |
| ENSG00000260766.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.026828404 |
Sensitive |
| ENSG00000260777.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.002742987 |
Sensitive |
| ENSG00000260814.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.008376213 |
Sensitive |
| ENSG00000260942.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.022839859 |
Sensitive |
| ENSG00000261126.3 |
Cytarabine |
Pancreatic adenocarcinoma |
0.025118926 |
Sensitive |
| ENSG00000261159.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.039999132 |
Sensitive |
| ENSG00000261242.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.016175958 |
Sensitive |
| ENSG00000261252.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.006326285 |
Sensitive |
| ENSG00000261280.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.008420426 |
Sensitive |
| ENSG00000261372.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.031906819 |
Sensitive |
| ENSG00000261428.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.034219245 |
Sensitive |
| ENSG00000261433.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.047983694 |
Sensitive |
| ENSG00000261766.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.039775594 |
Sensitive |
| ENSG00000261775.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.038251852 |
Sensitive |
| ENSG00000261886.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.043841357 |
Sensitive |
| ENSG00000262098.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.047809978 |
Sensitive |
| ENSG00000262228.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.040353829 |
Sensitive |
| ENSG00000262482.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.039341775 |
Sensitive |
| ENSG00000262580.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.040135163 |
Sensitive |
| ENSG00000262837.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.002292754 |
Sensitive |
| ENSG00000262879.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.044697334 |
Sensitive |
| ENSG00000263164.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.04597415 |
Sensitive |
| ENSG00000263350.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.031474932 |
Sensitive |
| ENSG00000263470.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.035036441 |
Sensitive |
| ENSG00000263766.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.026166979 |
Sensitive |
| ENSG00000264207.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.049468905 |
Sensitive |
| ENSG00000264808.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.020625268 |
Sensitive |
| ENSG00000266824.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.042283368 |
Sensitive |
| ENSG00000266904.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.030809297 |
Sensitive |
| ENSG00000266926.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.006128355 |
Sensitive |
| ENSG00000266969.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.025214327 |
Sensitive |
| ENSG00000266999.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.01855841 |
Sensitive |
| ENSG00000267067.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.024148782 |
Sensitive |
| ENSG00000267080.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.001903719 |
Sensitive |
| ENSG00000267093.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.04867436 |
Sensitive |
| ENSG00000267150.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.020815145 |
Sensitive |
| ENSG00000267174.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.049406983 |
Sensitive |
| ENSG00000267244.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.005757238 |
Sensitive |
| ENSG00000267248.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.006350354 |
Sensitive |
| ENSG00000267289.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.019033954 |
Sensitive |
| ENSG00000267321.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.031390735 |
Sensitive |
| ENSG00000267334.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.003122094 |
Sensitive |
| ENSG00000267419.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.02075449 |
Sensitive |
| ENSG00000267480.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.000348654 |
Sensitive |
| ENSG00000267510.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.040124031 |
Sensitive |
| ENSG00000267549.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.046645376 |
Sensitive |
| ENSG00000267568.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.021983545 |
Sensitive |
| ENSG00000267655.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.027669194 |
Sensitive |
| ENSG00000267666.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.015378138 |
Sensitive |
| ENSG00000267715.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.002072386 |
Sensitive |
| ENSG00000267730.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.015575767 |
Sensitive |
| ENSG00000267798.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.001909849 |
Sensitive |
| ENSG00000268015.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.000757319 |
Sensitive |
| ENSG00000268049.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.027489784 |
Sensitive |
| ENSG00000268230.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.02358093 |
Sensitive |
| ENSG00000268262.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.010877613 |
Sensitive |
| ENSG00000268375.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.002730577 |
Sensitive |
| ENSG00000268401.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.031865749 |
Sensitive |
| ENSG00000268836.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.000625407 |
Sensitive |
| ENSG00000268945.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.041607042 |
Sensitive |
| ENSG00000269044.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.032621345 |
Sensitive |
| ENSG00000269091.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.044184074 |
Sensitive |
| ENSG00000269107.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.048104571 |
Sensitive |
| ENSG00000269235.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.001705974 |
Sensitive |
| ENSG00000269290.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.031612261 |
Sensitive |
| ENSG00000269352.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.002844111 |
Sensitive |
| ENSG00000269814.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.045615905 |
Sensitive |
| ENSG00000269843.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.025786963 |
Sensitive |
| ENSG00000269867.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.011679711 |
Sensitive |
| ENSG00000269903.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.010677383 |
Sensitive |
| ENSG00000269947.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.049398456 |
Sensitive |
| ENSG00000269949.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.00449362 |
Sensitive |
| ENSG00000269973.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.016651818 |
Sensitive |
| ENSG00000269974.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.031229439 |
Sensitive |
| ENSG00000270006.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.004774388 |
Sensitive |
| ENSG00000270020.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.04425362 |
Sensitive |
| ENSG00000270028.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.008198401 |
Sensitive |
| ENSG00000270055.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.009285376 |
Sensitive |
| ENSG00000270081.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.011431208 |
Sensitive |
| ENSG00000270091.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.016050311 |
Sensitive |
| ENSG00000270210.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.033026181 |
Sensitive |
| ENSG00000271384.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.003821008 |
Sensitive |
| ENSG00000271427.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.031186087 |
Sensitive |
| ENSG00000271755.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.023709331 |
Sensitive |
| ENSG00000271833.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.00943662 |
Sensitive |
| ENSG00000271871.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.010231704 |
Sensitive |
| ENSG00000271914.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.016324167 |
Sensitive |
| ENSG00000271964.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.042064877 |
Sensitive |
| ENSG00000271991.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.016447221 |
Sensitive |
| ENSG00000271998.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.01486265 |
Sensitive |
| ENSG00000272077.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.030113366 |
Sensitive |
| ENSG00000272142.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.042932979 |
Sensitive |
| ENSG00000272226.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.043995528 |
Sensitive |
| ENSG00000272265.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.018216811 |
Sensitive |
| ENSG00000272288.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.001561337 |
Sensitive |
| ENSG00000272365.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.049999428 |
Sensitive |
| ENSG00000272375.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.022855625 |
Sensitive |
| ENSG00000272444.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.011972207 |
Sensitive |
| ENSG00000272452.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.02958729 |
Sensitive |
| ENSG00000272462.2 |
Cytarabine |
Pancreatic adenocarcinoma |
0.037329375 |
Sensitive |
| ENSG00000272525.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.016607432 |
Sensitive |
| ENSG00000272645.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.047975641 |
Sensitive |
| ENSG00000272646.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.013079049 |
Sensitive |
| ENSG00000272663.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.034621626 |
Sensitive |
| ENSG00000272688.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.036207131 |
Sensitive |
| ENSG00000272699.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.018329091 |
Sensitive |
| ENSG00000272702.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.023050458 |
Sensitive |
| ENSG00000272716.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.016320453 |
Sensitive |
| ENSG00000272758.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.007126746 |
Sensitive |
| ENSG00000272760.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.02632017 |
Sensitive |
| ENSG00000272829.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.007736772 |
Sensitive |
| ENSG00000272864.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.002417584 |
Sensitive |
| ENSG00000272960.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.025521921 |
Sensitive |
| ENSG00000273008.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.034402263 |
Sensitive |
| ENSG00000273081.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.029812554 |
Sensitive |
| ENSG00000273142.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.035754601 |
Sensitive |
| ENSG00000273181.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.047271356 |
Sensitive |
| ENSG00000273183.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.032089689 |
Sensitive |
| ENSG00000273290.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.001453254 |
Sensitive |
| ENSG00000273306.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.002915346 |
Sensitive |
| ENSG00000273335.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.043187887 |
Sensitive |
| ENSG00000273344.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.027827282 |
Sensitive |
| ENSG00000273355.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.013796579 |
Sensitive |
| ENSG00000273373.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.01823004 |
Sensitive |
| ENSG00000273483.1 |
Cytarabine |
Pancreatic adenocarcinoma |
0.035283191 |
Sensitive |
| ENSG00000152931.7 |
Cytarabine |
Sarcoma |
0.019214853 |
Sensitive |
| ENSG00000179743.2 |
Cytarabine |
Sarcoma |
0.022812524 |
Sensitive |
| ENSG00000215869.3 |
Cytarabine |
Sarcoma |
0.013722248 |
Sensitive |
| ENSG00000224138.1 |
Cytarabine |
Sarcoma |
0.022112052 |
Sensitive |
| ENSG00000225235.1 |
Cytarabine |
Sarcoma |
0.047470468 |
Sensitive |
| ENSG00000227039.2 |
Cytarabine |
Sarcoma |
0.022162006 |
Sensitive |
| ENSG00000227542.1 |
Cytarabine |
Sarcoma |
0.002057756 |
Sensitive |
| ENSG00000228065.6 |
Cytarabine |
Sarcoma |
0.028464207 |
Sensitive |
| ENSG00000228506.1 |
Cytarabine |
Sarcoma |
0.023657406 |
Sensitive |
| ENSG00000228779.1 |
Cytarabine |
Sarcoma |
0.041833421 |
Sensitive |
| ENSG00000228852.2 |
Cytarabine |
Sarcoma |
0.027127987 |
Sensitive |
| ENSG00000229589.1 |
Cytarabine |
Sarcoma |
0.002694737 |
Sensitive |
| ENSG00000230176.2 |
Cytarabine |
Sarcoma |
0.043717243 |
Sensitive |
| ENSG00000230530.1 |
Cytarabine |
Sarcoma |
0.023821995 |
Sensitive |
| ENSG00000233016.2 |
Cytarabine |
Sarcoma |
0.04288575 |
Sensitive |
| ENSG00000234880.1 |
Cytarabine |
Sarcoma |
0.020170411 |
Sensitive |
| ENSG00000235079.1 |
Cytarabine |
Sarcoma |
0.0427244 |
Sensitive |
| ENSG00000236859.2 |
Cytarabine |
Sarcoma |
0.021335156 |
Sensitive |
| ENSG00000240211.1 |
Cytarabine |
Sarcoma |
0.049504211 |
Sensitive |
| ENSG00000240291.1 |
Cytarabine |
Sarcoma |
0.035767203 |
Sensitive |
| ENSG00000246174.3 |
Cytarabine |
Sarcoma |
0.031749214 |
Sensitive |
| ENSG00000248664.1 |
Cytarabine |
Sarcoma |
0.009370956 |
Sensitive |
| ENSG00000250734.2 |
Cytarabine |
Sarcoma |
0.024427861 |
Sensitive |
| ENSG00000253559.1 |
Cytarabine |
Sarcoma |
0.038391644 |
Sensitive |
| ENSG00000254607.2 |
Cytarabine |
Sarcoma |
0.01714019 |
Sensitive |
| ENSG00000259595.1 |
Cytarabine |
Sarcoma |
0.02655056 |
Sensitive |
| ENSG00000259736.1 |
Cytarabine |
Sarcoma |
0.04689245 |
Sensitive |
| ENSG00000260285.1 |
Cytarabine |
Sarcoma |
0.028693213 |
Sensitive |
| ENSG00000260526.1 |
Cytarabine |
Sarcoma |
0.006274843 |
Sensitive |
| ENSG00000260949.1 |
Cytarabine |
Sarcoma |
0.01211725 |
Sensitive |
| ENSG00000262228.1 |
Cytarabine |
Sarcoma |
0.049558245 |
Sensitive |
| ENSG00000267130.1 |
Cytarabine |
Sarcoma |
0.030092209 |
Sensitive |
| ENSG00000267737.1 |
Cytarabine |
Sarcoma |
0.034123307 |
Sensitive |
| ENSG00000270081.1 |
Cytarabine |
Sarcoma |
0.046355771 |
Sensitive |
| ENSG00000270083.1 |
Cytarabine |
Sarcoma |
0.043881281 |
Sensitive |
| ENSG00000270419.1 |
Cytarabine |
Sarcoma |
0.008336882 |
Sensitive |
| ENSG00000270426.1 |
Cytarabine |
Sarcoma |
0.014339232 |
Sensitive |
| ENSG00000270557.1 |
Cytarabine |
Sarcoma |
0.022763517 |
Sensitive |
| ENSG00000271815.1 |
Cytarabine |
Sarcoma |
0.034092386 |
Sensitive |
| ENSG00000272128.1 |
Cytarabine |
Sarcoma |
0.046327242 |
Sensitive |
| ENSG00000272558.1 |
Cytarabine |
Sarcoma |
0.018801567 |
Sensitive |
| ENSG00000272744.1 |
Cytarabine |
Sarcoma |
0.035356417 |
Sensitive |
| ENSG00000272769.1 |
Cytarabine |
Sarcoma |
0.028793081 |
Sensitive |
| ENSG00000164621.5 |
Cytarabine |
Skin cutaneous melanoma |
0.045491462 |
Sensitive |
| ENSG00000177640.11 |
Cytarabine |
Skin cutaneous melanoma |
0.022291741 |
Sensitive |
| ENSG00000203706.4 |
Cytarabine |
Skin cutaneous melanoma |
0.04900792 |
Sensitive |
| ENSG00000203808.6 |
Cytarabine |
Skin cutaneous melanoma |
0.035024807 |
Sensitive |
| ENSG00000224644.1 |
Cytarabine |
Skin cutaneous melanoma |
0.033788029 |
Sensitive |
| ENSG00000226291.1 |
Cytarabine |
Skin cutaneous melanoma |
0.008328812 |
Sensitive |
| ENSG00000226381.3 |
Cytarabine |
Skin cutaneous melanoma |
0.003012848 |
Sensitive |
| ENSG00000227117.2 |
Cytarabine |
Skin cutaneous melanoma |
0.030091954 |
Sensitive |
| ENSG00000227398.3 |
Cytarabine |
Skin cutaneous melanoma |
0.040334401 |
Sensitive |
| ENSG00000228350.1 |
Cytarabine |
Skin cutaneous melanoma |
0.005136786 |
Sensitive |
| ENSG00000228506.1 |
Cytarabine |
Skin cutaneous melanoma |
0.029226004 |
Sensitive |
| ENSG00000228801.5 |
Cytarabine |
Skin cutaneous melanoma |
0.035694673 |
Sensitive |
| ENSG00000229124.2 |
Cytarabine |
Skin cutaneous melanoma |
0.043607739 |
Sensitive |
| ENSG00000229582.2 |
Cytarabine |
Skin cutaneous melanoma |
0.026200216 |
Sensitive |
| ENSG00000230065.1 |
Cytarabine |
Skin cutaneous melanoma |
0.027366406 |
Sensitive |
| ENSG00000231521.1 |
Cytarabine |
Skin cutaneous melanoma |
0.009499916 |
Sensitive |
| ENSG00000231652.2 |
Cytarabine |
Skin cutaneous melanoma |
0.034167368 |
Sensitive |
| ENSG00000231969.1 |
Cytarabine |
Skin cutaneous melanoma |
0.047487051 |
Sensitive |
| ENSG00000232442.1 |
Cytarabine |
Skin cutaneous melanoma |
0.042583309 |
Sensitive |
| ENSG00000232519.2 |
Cytarabine |
Skin cutaneous melanoma |
0.01525755 |
Sensitive |
| ENSG00000233064.2 |
Cytarabine |
Skin cutaneous melanoma |
0.005325778 |
Sensitive |
| ENSG00000235257.4 |
Cytarabine |
Skin cutaneous melanoma |
0.004768095 |
Sensitive |
| ENSG00000235381.1 |
Cytarabine |
Skin cutaneous melanoma |
0.045092596 |
Sensitive |
| ENSG00000237738.1 |
Cytarabine |
Skin cutaneous melanoma |
0.037664154 |
Sensitive |
| ENSG00000239002.2 |
Cytarabine |
Skin cutaneous melanoma |
0.039930201 |
Sensitive |
| ENSG00000244161.1 |
Cytarabine |
Skin cutaneous melanoma |
0.031459782 |
Sensitive |
| ENSG00000246792.2 |
Cytarabine |
Skin cutaneous melanoma |
0.047564691 |
Sensitive |
| ENSG00000247982.2 |
Cytarabine |
Skin cutaneous melanoma |
0.001801543 |
Sensitive |
| ENSG00000248514.1 |
Cytarabine |
Skin cutaneous melanoma |
0.044839573 |
Sensitive |
| ENSG00000250616.2 |
Cytarabine |
Skin cutaneous melanoma |
0.002761041 |
Sensitive |
| ENSG00000251072.2 |
Cytarabine |
Skin cutaneous melanoma |
0.003934112 |
Sensitive |
| ENSG00000251151.2 |
Cytarabine |
Skin cutaneous melanoma |
0.032559376 |
Sensitive |
| ENSG00000253930.1 |
Cytarabine |
Skin cutaneous melanoma |
0.036531657 |
Sensitive |
| ENSG00000258082.1 |
Cytarabine |
Skin cutaneous melanoma |
0.006190214 |
Sensitive |
| ENSG00000258558.1 |
Cytarabine |
Skin cutaneous melanoma |
0.043052527 |
Sensitive |
| ENSG00000258857.1 |
Cytarabine |
Skin cutaneous melanoma |
0.047029103 |
Sensitive |
| ENSG00000258922.1 |
Cytarabine |
Skin cutaneous melanoma |
0.026826003 |
Sensitive |
| ENSG00000258952.1 |
Cytarabine |
Skin cutaneous melanoma |
0.024237522 |
Sensitive |
| ENSG00000259209.1 |
Cytarabine |
Skin cutaneous melanoma |
0.022840738 |
Sensitive |
| ENSG00000259606.2 |
Cytarabine |
Skin cutaneous melanoma |
0.037449822 |
Sensitive |
| ENSG00000259891.1 |
Cytarabine |
Skin cutaneous melanoma |
0.019571873 |
Sensitive |
| ENSG00000260037.1 |
Cytarabine |
Skin cutaneous melanoma |
0.031425768 |
Sensitive |
| ENSG00000260281.1 |
Cytarabine |
Skin cutaneous melanoma |
0.010844114 |
Sensitive |
| ENSG00000260468.1 |
Cytarabine |
Skin cutaneous melanoma |
0.025779015 |
Sensitive |
| ENSG00000260579.1 |
Cytarabine |
Skin cutaneous melanoma |
0.018527102 |
Sensitive |
| ENSG00000260626.1 |
Cytarabine |
Skin cutaneous melanoma |
0.009221047 |
Sensitive |
| ENSG00000260986.1 |
Cytarabine |
Skin cutaneous melanoma |
0.033336883 |
Sensitive |
| ENSG00000260992.1 |
Cytarabine |
Skin cutaneous melanoma |
0.030213311 |
Sensitive |
| ENSG00000261204.1 |
Cytarabine |
Skin cutaneous melanoma |
0.00672214 |
Sensitive |
| ENSG00000261574.1 |
Cytarabine |
Skin cutaneous melanoma |
0.028675705 |
Sensitive |
| ENSG00000261697.1 |
Cytarabine |
Skin cutaneous melanoma |
0.036752494 |
Sensitive |
| ENSG00000262362.1 |
Cytarabine |
Skin cutaneous melanoma |
0.007151774 |
Sensitive |
| ENSG00000263727.1 |
Cytarabine |
Skin cutaneous melanoma |
0.021984026 |
Sensitive |
| ENSG00000263786.1 |
Cytarabine |
Skin cutaneous melanoma |
0.021601979 |
Sensitive |
| ENSG00000264207.1 |
Cytarabine |
Skin cutaneous melanoma |
0.047413285 |
Sensitive |
| ENSG00000265739.1 |
Cytarabine |
Skin cutaneous melanoma |
0.044629051 |
Sensitive |
| ENSG00000266993.1 |
Cytarabine |
Skin cutaneous melanoma |
0.001391392 |
Sensitive |
| ENSG00000267288.1 |
Cytarabine |
Skin cutaneous melanoma |
0.030309963 |
Sensitive |
| ENSG00000269290.1 |
Cytarabine |
Skin cutaneous melanoma |
0.028333778 |
Sensitive |
| ENSG00000270223.1 |
Cytarabine |
Skin cutaneous melanoma |
0.047781724 |
Sensitive |
| ENSG00000271993.1 |
Cytarabine |
Skin cutaneous melanoma |
0.03848409 |
Sensitive |
| ENSG00000272102.1 |
Cytarabine |
Skin cutaneous melanoma |
0.007103641 |
Sensitive |
| ENSG00000272660.1 |
Cytarabine |
Skin cutaneous melanoma |
0.001474233 |
Sensitive |
| ENSG00000272688.1 |
Cytarabine |
Skin cutaneous melanoma |
0.008505044 |
Sensitive |
| ENSG00000272744.1 |
Cytarabine |
Skin cutaneous melanoma |
0.001125531 |
Sensitive |
| ENSG00000273153.1 |
Cytarabine |
Skin cutaneous melanoma |
0.04903215 |
Sensitive |
| ENSG00000273162.1 |
Cytarabine |
Skin cutaneous melanoma |
0.033467943 |
Sensitive |
| ENSG00000273248.1 |
Cytarabine |
Skin cutaneous melanoma |
0.026506953 |
Sensitive |
| ENSG00000273265.1 |
Cytarabine |
Skin cutaneous melanoma |
0.04911304 |
Sensitive |
| ENSG00000273305.1 |
Cytarabine |
Skin cutaneous melanoma |
0.030086011 |
Sensitive |
| ENSG00000273416.1 |
Cytarabine |
Skin cutaneous melanoma |
0.019382125 |
Sensitive |
| ENSG00000214650.2 |
Cytarabine |
Stomach adenocarcinoma |
0.032122751 |
Sensitive |
| ENSG00000215374.5 |
Cytarabine |
Stomach adenocarcinoma |
0.027359392 |
Sensitive |
| ENSG00000223374.1 |
Cytarabine |
Stomach adenocarcinoma |
0.018574857 |
Sensitive |
| ENSG00000224356.3 |
Cytarabine |
Stomach adenocarcinoma |
0.036148525 |
Sensitive |
| ENSG00000224789.1 |
Cytarabine |
Stomach adenocarcinoma |
0.028027352 |
Sensitive |
| ENSG00000224818.1 |
Cytarabine |
Stomach adenocarcinoma |
0.025105075 |
Sensitive |
| ENSG00000226383.1 |
Cytarabine |
Stomach adenocarcinoma |
0.047128115 |
Sensitive |
| ENSG00000227285.1 |
Cytarabine |
Stomach adenocarcinoma |
0.003101423 |
Sensitive |
| ENSG00000228463.4 |
Cytarabine |
Stomach adenocarcinoma |
0.04103137 |
Sensitive |
| ENSG00000229867.1 |
Cytarabine |
Stomach adenocarcinoma |
0.021368696 |
Sensitive |
| ENSG00000230002.2 |
Cytarabine |
Stomach adenocarcinoma |
0.029913561 |
Sensitive |
| ENSG00000231073.1 |
Cytarabine |
Stomach adenocarcinoma |
0.040633081 |
Sensitive |
| ENSG00000231616.4 |
Cytarabine |
Stomach adenocarcinoma |
0.006692479 |
Sensitive |
| ENSG00000232756.1 |
Cytarabine |
Stomach adenocarcinoma |
0.037234732 |
Sensitive |
| ENSG00000234281.1 |
Cytarabine |
Stomach adenocarcinoma |
0.018388635 |
Sensitive |
| ENSG00000235806.1 |
Cytarabine |
Stomach adenocarcinoma |
0.01544309 |
Sensitive |
| ENSG00000245614.2 |
Cytarabine |
Stomach adenocarcinoma |
0.028606379 |
Sensitive |
| ENSG00000245937.3 |
Cytarabine |
Stomach adenocarcinoma |
0.040017408 |
Sensitive |
| ENSG00000246526.2 |
Cytarabine |
Stomach adenocarcinoma |
0.047615976 |
Sensitive |
| ENSG00000248175.1 |
Cytarabine |
Stomach adenocarcinoma |
0.018082409 |
Sensitive |
| ENSG00000250986.1 |
Cytarabine |
Stomach adenocarcinoma |
0.022625238 |
Sensitive |
| ENSG00000251151.2 |
Cytarabine |
Stomach adenocarcinoma |
0.042098819 |
Sensitive |
| ENSG00000251307.1 |
Cytarabine |
Stomach adenocarcinoma |
0.00967361 |
Sensitive |
| ENSG00000256050.2 |
Cytarabine |
Stomach adenocarcinoma |
0.044074925 |
Sensitive |
| ENSG00000258017.1 |
Cytarabine |
Stomach adenocarcinoma |
0.025051402 |
Sensitive |
| ENSG00000258077.2 |
Cytarabine |
Stomach adenocarcinoma |
0.014750648 |
Sensitive |
| ENSG00000259209.1 |
Cytarabine |
Stomach adenocarcinoma |
0.035098809 |
Sensitive |
| ENSG00000259240.1 |
Cytarabine |
Stomach adenocarcinoma |
0.006364782 |
Sensitive |
| ENSG00000260920.1 |
Cytarabine |
Stomach adenocarcinoma |
0.008471279 |
Sensitive |
| ENSG00000261216.1 |
Cytarabine |
Stomach adenocarcinoma |
0.043039211 |
Sensitive |
| ENSG00000261338.1 |
Cytarabine |
Stomach adenocarcinoma |
0.048477927 |
Sensitive |
| ENSG00000261490.1 |
Cytarabine |
Stomach adenocarcinoma |
0.015867262 |
Sensitive |
| ENSG00000261840.1 |
Cytarabine |
Stomach adenocarcinoma |
0.008562998 |
Sensitive |
| ENSG00000262136.1 |
Cytarabine |
Stomach adenocarcinoma |
0.000501446 |
Sensitive |
| ENSG00000263327.2 |
Cytarabine |
Stomach adenocarcinoma |
0.042395584 |
Sensitive |
| ENSG00000265242.1 |
Cytarabine |
Stomach adenocarcinoma |
0.016559539 |
Sensitive |
| ENSG00000267567.1 |
Cytarabine |
Stomach adenocarcinoma |
0.007680751 |
Sensitive |
| ENSG00000268201.1 |
Cytarabine |
Stomach adenocarcinoma |
0.027974866 |
Sensitive |
| ENSG00000268938.2 |
Cytarabine |
Stomach adenocarcinoma |
0.034212179 |
Sensitive |
| ENSG00000270726.1 |
Cytarabine |
Stomach adenocarcinoma |
0.03374106 |
Sensitive |
| ENSG00000271789.1 |
Cytarabine |
Stomach adenocarcinoma |
0.027300816 |
Sensitive |
| ENSG00000271983.1 |
Cytarabine |
Stomach adenocarcinoma |
0.002436832 |
Sensitive |
| ENSG00000272087.1 |
Cytarabine |
Stomach adenocarcinoma |
0.036010089 |
Sensitive |
| ENSG00000272368.1 |
Cytarabine |
Stomach adenocarcinoma |
0.010052138 |
Sensitive |
| ENSG00000272808.1 |
Cytarabine |
Stomach adenocarcinoma |
0.022689483 |
Sensitive |
| ENSG00000272888.1 |
Cytarabine |
Stomach adenocarcinoma |
0.042955238 |
Sensitive |
| ENSG00000272931.1 |
Cytarabine |
Stomach adenocarcinoma |
0.031589643 |
Sensitive |
| ENSG00000273004.1 |
Cytarabine |
Stomach adenocarcinoma |
0.032635498 |
Sensitive |
| ENSG00000273066.1 |
Cytarabine |
Stomach adenocarcinoma |
0.023342653 |
Sensitive |
| ENSG00000273183.1 |
Cytarabine |
Stomach adenocarcinoma |
0.043298898 |
Sensitive |
